0001642159 2022-01-01 2022-03-31 0001642159 dei:BusinessContactMember 2022-01-01 2022-03-31 0001642159 2021-12-31 0001642159 2020-12-31 0001642159 2022-03-31 0001642159 2021-01-01 2021-12-31 0001642159 2020-01-01 2020-12-31 0001642159 2021-01-01 2021-03-31 0001642159 us-gaap:CommonStockMember 2019-12-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001642159 us-gaap:RetainedEarningsMember 2019-12-31 0001642159 2019-12-31 0001642159 us-gaap:CommonStockMember 2020-12-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001642159 us-gaap:RetainedEarningsMember 2020-12-31 0001642159 us-gaap:CommonStockMember 2021-12-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001642159 us-gaap:RetainedEarningsMember 2021-12-31 0001642159 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001642159 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001642159 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001642159 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001642159 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001642159 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001642159 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001642159 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001642159 us-gaap:CommonStockMember 2021-03-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001642159 us-gaap:RetainedEarningsMember 2021-03-31 0001642159 2021-03-31 0001642159 us-gaap:CommonStockMember 2022-03-31 0001642159 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001642159 us-gaap:RetainedEarningsMember 2022-03-31 0001642159 SIGN:SigynStockholderMember SIGN:ShareExchangeAgreementMember 2020-10-19 0001642159 SIGN:ShareExchangeAgreementMember 2020-10-18 2020-10-19 0001642159 us-gaap:SubsequentEventMember 2022-03-14 0001642159 SIGN:NonAffiliateShareholdersMember us-gaap:SubsequentEventMember 2022-03-14 0001642159 SIGN:ShareExchangeAgreementMember 2020-10-19 0001642159 us-gaap:SubsequentEventMember 2022-05-13 0001642159 SIGN:NonAffiliateShareholdersMember us-gaap:SubsequentEventMember 2022-05-13 0001642159 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001642159 us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001642159 srt:RevisionOfPriorPeriodReclassificationAdjustmentMember 2022-03-31 0001642159 us-gaap:OfficeEquipmentMember 2021-01-01 2021-12-31 0001642159 us-gaap:OfficeEquipmentMember 2021-12-31 0001642159 us-gaap:OfficeEquipmentMember 2020-12-31 0001642159 us-gaap:ComputerEquipmentMember 2021-01-01 2021-12-31 0001642159 us-gaap:ComputerEquipmentMember 2021-12-31 0001642159 us-gaap:ComputerEquipmentMember 2020-12-31 0001642159 us-gaap:OfficeEquipmentMember 2022-01-01 2022-03-31 0001642159 us-gaap:OfficeEquipmentMember 2022-03-31 0001642159 us-gaap:ComputerEquipmentMember 2022-01-01 2022-03-31 0001642159 us-gaap:ComputerEquipmentMember 2022-03-31 0001642159 us-gaap:TrademarksMember 2021-01-01 2021-12-31 0001642159 us-gaap:TrademarksMember 2021-12-31 0001642159 us-gaap:TrademarksMember 2020-12-31 0001642159 SIGN:WebsiteMember 2021-01-01 2021-12-31 0001642159 SIGN:WebsiteMember 2021-12-31 0001642159 SIGN:WebsiteMember 2020-12-31 0001642159 SIGN:ConvertiblePromissoryNoteOneMember 2021-12-31 0001642159 SIGN:ConvertiblePromissoryNoteOneMember 2020-12-31 0001642159 SIGN:ConvertiblePromissoryNoteTwoMember 2021-12-31 0001642159 SIGN:ConvertiblePromissoryNoteTwoMember 2020-12-31 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember 2021-12-31 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember 2020-12-31 0001642159 SIGN:ConvertiblePromissoryNoteOneMember 2022-03-31 0001642159 SIGN:ConvertiblePromissoryNoteTwoMember 2022-03-31 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember 2022-03-31 0001642159 SIGN:ConvertiblePromissoryNoteFourMember 2022-03-31 0001642159 SIGN:ConvertiblePromissoryNoteFourMember 2021-12-31 0001642159 SIGN:ConvertiblePromissoryNoteOneMember 2020-01-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember 2020-01-25 2020-01-28 0001642159 SIGN:ConvertiblePromissoryNoteTwoMember 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember 2020-06-20 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember 2020-09-17 0001642159 SIGN:ConvertiblePromissoryNoteFourMember 2020-09-15 2020-09-17 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:OsherCapitalPartnersLLCMember 2021-10-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:OsherCapitalPartnersLLCMember 2021-10-27 2021-10-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember 2020-01-26 2020-01-28 0001642159 SIGN:ConvertiblePromissoryNoteTwoMember 2020-06-20 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember 2020-09-15 2020-09-17 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember SIGN:OsherCapitalPartnersLLCMember 2021-10-28 0001642159 SIGN:ConvertiblePromissoryNoteThreeMember SIGN:OsherCapitalPartnersLLCMember 2021-10-27 2021-10-28 0001642159 SIGN:ConvertiblePromissoryNoteFourMember 2022-03-23 0001642159 SIGN:ConvertiblePromissoryNoteFourMember 2022-03-22 2022-03-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-01-26 2020-01-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-01-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:AmendedConvertibleDebtAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:AmendedConvertibleDebtAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-10-18 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-19 2021-10-22 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-21 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-22 0001642159 SIGN:PreviousNoteholderOneMember SIGN:ConvertiblePromissoryNoteTwoMember SIGN:SecuritiesPurchaseAgreementMember 2020-06-21 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-06-22 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-06-21 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:AmendedConvertibleDebtAgreementTwoMember SIGN:OsherCapitalPartnersLLCMember 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-18 2021-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-21 2021-10-22 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-15 2020-09-17 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-17 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:AmendedConvertibleDebtAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-17 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:AmendedConvertibleDebtAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-15 2020-09-17 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-27 2021-10-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-28 0001642159 SIGN:ConvertiblePromissoryNoteTwoMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-06-21 2020-06-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:AmendedConvertibleDebtAgreementTwoMember SIGN:OsherCapitalPartnersLLCMember 2020-06-23 0001642159 SIGN:PreviousNoteholderOneMember SIGN:ConvertiblePromissoryNoteTwoMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-18 2020-10-20 0001642159 SIGN:PreviousNoteholderOneMember SIGN:ConvertiblePromissoryNoteTwoMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-12-02 0001642159 SIGN:ConvertiblePromissoryNoteTwoMember SIGN:SecuritiesPurchaseAgreementMember SIGN:PreviousNoteholderOneMember 2020-12-02 0001642159 SIGN:PreviousNoteholderTwoMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-08-16 2020-08-18 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-08-18 0001642159 SIGN:PreviousNoteholderTwoMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-08-18 0001642159 SIGN:PreviousNoteholderTwoMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-20 0001642159 SIGN:PreviousNoteholderTwoMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-18 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-10-28 0001642159 SIGN:PreviousNoteholderTwoMember SIGN:ConvertiblePromissoryNoteMember us-gaap:CommonStockMember 2020-10-28 0001642159 SIGN:PreviousNoteholderTwoMember SIGN:ConvertiblePromissoryNoteMember us-gaap:CommonStockMember 2021-02-19 0001642159 SIGN:PreviousNoteholderThreeMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-16 2020-09-18 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-18 0001642159 SIGN:PreviousNoteholderThreeMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-18 0001642159 SIGN:PreviousNoteholderThreeMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementTwoMember 2020-10-20 0001642159 SIGN:PreviousNoteholderThreeMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementTwoMember 2020-10-18 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember 2020-12-02 0001642159 SIGN:PreviousNoteholderThreeMember SIGN:ConvertiblePromissoryNoteMember us-gaap:CommonStockMember 2020-12-02 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-19 2020-09-21 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-21 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-21 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2021-10-20 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-18 2020-10-20 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-11-05 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2021-11-05 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-26 2020-09-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-28 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-28 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-20 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2021-10-18 2021-10-20 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-27 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember us-gaap:CommonStockMember 2020-10-27 0001642159 SIGN:PreviousNoteholderSixMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-26 2020-09-29 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-09-29 0001642159 SIGN:PreviousNoteholderSixMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2020-09-29 0001642159 SIGN:PreviousNoteholderSixMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-20 0001642159 SIGN:PreviousNoteholderSixMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-18 2020-10-20 0001642159 SIGN:PreviousNoteholderFiveMember SIGN:ConvertiblePromissoryNoteMember SIGN:AmendedConvertibleDebtAgreementMember 2020-10-26 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-02-09 2021-02-10 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-02-10 0001642159 SIGN:PreviousNoteholderSevenMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2021-02-10 0001642159 SIGN:PreviousNoteholderSevenMember SIGN:ConvertiblePromissoryNoteMember us-gaap:CommonStockMember 2021-05-10 0001642159 SIGN:PreviousNoteholderEightMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2021-05-04 0001642159 SIGN:PreviousNoteholderEightMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2021-05-01 2021-05-04 0001642159 SIGN:PreviousNoteholderSevenMember SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2021-02-08 2021-02-10 0001642159 SIGN:PreviousNoteholderSevenMember SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember 2021-02-10 0001642159 SIGN:PreviousNoteholderSevenMember SIGN:ConvertiblePromissoryNoteMember us-gaap:CommonStockMember 2021-10-25 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:OsherCapitalPartnersLLCMember 2022-03-21 2022-03-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:OsherCapitalPartnersLLCMember 2022-03-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:BrioCapitalMasterFundLtdMember 2022-03-21 2022-03-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:BrioCapitalMasterFundLtdMember 2022-03-23 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-10-18 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:AmendedConvertibleDebtAgreementTwoMember SIGN:OsherCapitalPartnersLLCMember 2020-10-18 2020-10-20 0001642159 SIGN:ConvertiblePromissoryNoteOneMember SIGN:SecuritiesPurchaseAgreementMember SIGN:OsherCapitalPartnersLLCMember 2020-10-20 0001642159 SIGN:OsherCapitalPartnersLLCMember 2021-10-27 2021-10-28 0001642159 SIGN:OsherCapitalPartnersLLCMember 2021-10-28 0001642159 SIGN:MarketingConsultingAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-25 0001642159 SIGN:MarketingConsultingAgreementMember SIGN:OsherCapitalPartnersLLCMember 2021-10-24 2021-10-25 0001642159 SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2021-10-18 2021-10-20 0001642159 SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2021-10-20 0001642159 SIGN:ConvertiblePromissoryNoteMember SIGN:SecuritiesPurchaseAgreementMember 2021-10-08 2021-10-20 0001642159 2021-10-12 2021-10-14 0001642159 2021-07-12 2021-07-14 0001642159 2021-05-01 2021-05-10 0001642159 2021-04-01 2021-04-30 0001642159 2021-04-30 0001642159 2021-05-10 0001642159 2021-04-01 2021-04-14 0001642159 SIGN:PreviousNoteholderMember 2021-02-19 0001642159 2021-01-12 2021-01-14 0001642159 SIGN:ThirdPartiesMember 2020-01-01 2020-12-31 0001642159 2020-10-18 2020-10-19 0001642159 SIGN:ConvertiblePromissoryNoteMember 2021-10-18 2021-10-22 0001642159 SIGN:ConvertiblePromissoryNoteMember 2021-10-22 0001642159 SIGN:ConvertiblePromissoryNoteMember 2021-01-01 2021-12-31 0001642159 SIGN:ConvertiblePromissoryNoteMember 2020-01-01 2020-12-31 0001642159 2021-04-13 2021-04-14 0001642159 SIGN:ConvertiblePromissoryNoteMember 2022-01-01 2022-03-31 0001642159 SIGN:ConvertiblePromissoryNoteMember 2021-01-01 2021-03-31 0001642159 2021-05-01 2021-05-27 0001642159 SIGN:ASC842Member 2021-06-15 0001642159 2021-05-26 2021-05-27 0001642159 SIGN:MrJoyceMember SIGN:EmploymentAgreementsMember 2021-01-01 2021-12-31 0001642159 SIGN:MrJoyceMember SIGN:EmploymentAgreementsMember 2020-12-31 0001642159 SIGN:MrJoyceMember SIGN:EmploymentAgreementsMember 2020-01-01 2020-12-31 0001642159 SIGN:ChiefTechnologyOfficerMember SIGN:EmploymentAgreementsMember 2021-01-01 2021-12-31 0001642159 SIGN:ChiefTechnologyOfficerMember SIGN:EmploymentAgreementsMember 2020-01-01 2020-12-31 0001642159 SIGN:CEOAndCTOMember 2021-07-20 2021-07-21 0001642159 SIGN:MrFerrellMember SIGN:EmploymentAgreementsMember 2022-03-08 2022-03-09 0001642159 SIGN:MrFerrellMember SIGN:EmploymentAgreementsMember 2022-01-01 2022-03-31 0001642159 SIGN:MrFerrellMember SIGN:EmploymentAgreementsMember 2021-01-01 2021-03-31 0001642159 us-gaap:SubsequentEventMember 2022-03-08 2022-03-09 0001642159 us-gaap:SubsequentEventMember 2022-03-09 0001642159 SIGN:ConvertiblePromissoryNoteOneMember us-gaap:SubsequentEventMember 2022-04-26 2022-04-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember us-gaap:SubsequentEventMember 2022-04-28 0001642159 SIGN:ConvertiblePromissoryNoteOneMember us-gaap:SubsequentEventMember 2022-05-08 2022-05-10 0001642159 SIGN:ConvertiblePromissoryNoteOneMember us-gaap:SubsequentEventMember 2022-05-10 iso4217:USD shares iso4217:USD shares pure 0001642159 false

P5Y

S-1 SIGYN THERAPEUTICS, INC. DE 47-2573116 2468 Historic Decatur Road Suite 140 San Diego CA 92106 (619) 353-0800 VCorp Services 18 Lafayette Place Woodmere NY 11598 (845) 425-0077 Non-accelerated Filer true true true

340956

84402

50000

586047

2075

393031

670449

28046

1728

5700

21905

262771

20711

710259

694082

39674

16005

1072

59707

53614

97832

647202

518668

46091

179

523

1251

734218

594903

240625

974843

594903

0.0001

1000000000

37295803

35201513

3730

3520

3997445

1356799

-4265759

-1261140

-264584

99179

710259

694082

705

734014

419362

1274203

496367

2008217

916434

-2008217

-916434

536047

30867

368205

61283

343156

-996402

-343156

-3004619

-1259590

-3004619

-1259590

-0.08

-0.17

36396585

7351272

500000

590

-1550

-910

33686169

3368

606813

610181

223560

129938

1015344

102

395898

396000

-1259590

35201513

3520

1356799

-1261140

99179

188000

249081

249100

188069

101972

1492000 149 1864851 1865000 57147 6 -6 357143

236679

236715

-3004619

37295803

3730

3997445

-4265759

-264584

-3004619

-1259590

2946

346

16205

10954

249100

-368205 -275333 61283 67823

30800

536047

2075

20711

23669

15095

-58635

59707

23603

523

-1774182

-829809

29264

10799

-29264

-10799

250000

925010

55000

1865000

2060000

925010

84402

340956

84402

101972 129938 188069 223560

126030

85495

236715 396000

NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES Corporate History and Background Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our business focus is the clinical advancement of Sigyn Therapy, a multi-function blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the leading cause of hospital deaths worldwide. We are advancing Sigyn Therapy to treat pathogen-associated conditions that precipitate sepsis and other high-mortality disorders that are not addressed with approved drug therapies. To address these unmet therapeutic needs, we designed Sigyn Therapy to extract pathogen sources of life-threating inflammation from the bloodstream in concert with the depletion of pro-inflammatory cytokines, whose dysregulated production (the cytokine storm) plays a prominent role in each of our therapeutic indication opportunities. In addition to sepsis, our candidate treatment indications include, but are not limited to; emerging pandemic threats, drug resistant pathogens, hepatic encephalopathy, bridge to liver transplant, and community-acquired pneumonia (“CAP”), which is a leading cause of death among infectious diseases, the leading cause of death in children under five years of age, and a catalyst for approximately 50% of sepsis and septic shock cases. Public Merger Agreement On October 19, 2020, Sigyn Therapeutics, Inc, a Delaware corporation (the “Registrant”) formerly known as Reign Resources Corporation, completed a Share Exchange Agreement (the “Agreement”) with Sigyn Therapeutics, Inc., a private entity incorporated in the State of Delaware on October 19, 2019. In the Share Exchange Agreement, we acquired <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20201019__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--SigynStockholderMember_zSDrdVE3vyM8" title="Percentage of acquisition ownership interest">100% of the issued and outstanding shares of privately held Sigyn Therapeutics Inc., common stock in exchange for <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_uPure_c20201018__20201019__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zCt5M3bpMYI8" title="Percentage of common stock outstanding">75% of the fully paid and nonassessable shares of our common stock outstanding (the “Acquisition”). In conjunction with the transaction, we changed our name from Reign Resources Corporation to Sigyn Therapeutics, Inc. pursuant to an amendment to our articles of incorporation that was filed with the State of Delaware. Subsequently, our trading symbol was changed to SIGY. The Acquisition was treated as a “tax-free exchange” under Section 368 of the Internal Revenue Code of 1986 and resulted in the private Sigyn Therapeutics corporate entity becoming a wholly owned subsidiary known as Sigyn Medical Corporation. Upon the closing of the Acquisition, we appointed James A. Joyce and Craig P. Roberts to serve as members of our Board of Directors. As of March 14, 2022, we have a total 37,295,803 shares issued and outstanding, of which <span id="xdx_902_ecustom--CommonStockSharesHeld_iI_c20220314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--NonAffiliateShareholdersMember_zX7srPSVRuq1" title="Common stock, shares held">11,655,803 shares are held by non-affiliate shareholders. About Sigyn Therapy Our business focus is the clinical advancement of Sigyn Therapy, a multi-function blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the leading cause of hospital deaths worldwide. We are advancing Sigyn Therapy to treat pathogen-associated conditions that precipitate sepsis and other high-mortality disorders that are not addressed with approved drug therapies. To address these unmet therapeutic needs, we designed Sigyn Therapy to extract pathogen sources of life-threating inflammation from the bloodstream in concert with the depletion of pro-inflammatory cytokines, whose dysregulated production (the cytokine storm) plays a prominent role in each of our therapeutic indication opportunities. In addition to sepsis, our candidate treatment indications include, but are not limited to; emerging pandemic threats, drug resistant pathogens, hepatic encephalopathy, bridge to liver transplant, and CAP, which is a leading cause of death among infectious diseases, the leading cause of death in children under five years of age, and a catalyst for approximately 50% of sepsis and septic shock cases. Post Public Merger Developments Since the consummation of our public merger on October 19, 2020, we have advanced Sigyn Therapy from conceptual design to clinical application. We initiated and completed six (6) in vitro blood plasma studies that have validated the ability of Sigyn Therapy to address a broad-spectrum of relevant therapeutic targets, including endotoxin (gram-negative bacterial toxin); peptidoglycan and lipoteichoic acid (gram-positive bacterial toxins); viral pathogens (including SARS-CoV-2); hepatic toxins (ammonia, bile acid, and bilirubin); CytoVesicles (extracellular vesicles that transport inflammatory cytokine cargos); and tumor necrosis factor alpha (TNF alpha), interleukin-1 beta (IL-1b), and interleukin 6 (IL-6), which are pro-inflammatory cytokines whose dysregulated production (the cytokine storm) precipitate sepsis and play a prominent role in each of our therapeutic opportunities. Subsequent to these milestone achievements, we announced the completion of in vivo animal studies on February 23, 2022, that demonstrated Sigyn Therapy to be safe and well tolerated. In the studies, Sigyn Therapy was administered via standard dialysis machines utilizing conventional blood-tubing sets, for periods of up to six hours in eight (8) porcine (pig) subjects, each weighing approximately 40-45 kilograms. The studies were comprised of a pilot phase (two subjects), which evaluated the feasibility of the study protocol in the first-in-mammal use of Sigyn Therapy; and an expansion phase (six subjects) to further assess treatment safety and refine pre-treatment set-up and operating procedures. Sigyn Therapy was well tolerated by all eight animal subjects and no serious adverse events were reported in any treated animal subject. Important criteria for treatment safety – including hemodynamic parameters, serum chemistries and hematologic measurements – were stable across all subjects. The studies were conducted by a clinical team at Innovative BioTherapies, Inc. (“IBT”), under a contract with the University of Michigan to utilize animal care, associated institutional review oversight, as well as surgical suite facilities located within the North Campus Research Complex. IBT is uniquely experienced in providing development services that support the clinical advancement of extracorporeal devices. The treatment protocol of the study was reviewed and approved by the University of Michigan Institutional Animal Care and Use Committee (IACUC). We plan to incorporate the data resulting from our in vivo and invitro studies into an Investigational Device Exemption (IDE) that we are drafting for submission to the FDA to support the potential initiation of human clinical studies.

0.50

0.75

37295803

11655803 0.50

NOTE 2 – BASIS OF PRESENTATION The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include all adjustments necessary for the fair presentation of the Company’s financial position and results of operations for the periods presented. The Company currently operates in one business segment. The Company is not organized by market and is managed and operated as one business. A single management team reports to the chief operating decision maker, the Chief Executive Officer, who comprehensively manages the entire business. The Company does not currently operate any separate lines of businesses or separate business entities. Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $4,265,759 at December 31, 2021, had a working capital deficit of approximately $341,000 at December 31, 2021, had net losses of $3,004,619 and $1,259,590 for the years ended December 31, 2021 and 2020, respectively, and net cash used in operating activities of $1,774,182 and $829,809 for the years ended December 31, 2021 and 2020, respectively, with no revenue earned since inception, and a lack of operational history. These matters raise substantial doubt about the Company’s ability to continue as a going concern. While the Company is attempting to expand its research and development activities, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of a private offering or an asset sale transaction. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While management believes in the viability of its strategy to generate revenues and in its ability to raise additional funds or transact an asset sale, there can be no assurances to that effect or on terms acceptable to the Company. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

-4265759

341000

-3004619

-1259590

-1774182

-829809

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to GAAP and have been consistently applied in the preparation of the financial statements. Use of Estimates The preparation of these consolidated financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of net sales and expenses during the reported periods. Actual results may differ from those estimates and such differences may be material to the consolidated financial statements. The more significant estimates and assumptions by management include among others: realizability of inventory, common stock valuation, and the recoverability of intangibles. The current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. Cash The Company’s cash is held in bank accounts in the United States and is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company has not experienced any cash losses. Income Taxes Income taxes are accounted for under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Balance Sheets in accordance with Accounting Standards Codification (“ASC”) ASC 740, Income Taxes, which established financial accounting and reporting standards for the effect of income taxes. The likelihood that its deferred tax assets will be recovered from future taxable income must be assessed and, to the extent that recovery is not likely, a valuation allowance is established. Changes in the valuation allowance in a period are recorded through the income tax provision in the consolidated Statements of Operations. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s consolidated financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company does not have a liability for unrecognized income tax benefits. Advertising and Marketing Costs Advertising expenses are recorded as general and administrative expenses when they are incurred. The Company had no advertising expenses for year ended December 31, 2021 and had $705 for the year ended December 31, 2020. Research and Development All research and development costs are expensed as incurred. The Company incurred research and development expense of $734,014 and $419,362 for the years ended December 31, 2021 and 2020, respectively. Inventories In conjunction with the October 19, 2020 Share Exchange Agreement, the Company kept the gem inventory of Reign Resources Corporation. Inventories are stated at the lower of cost or market (net realizable value) on a lot basis each quarter. A lot is determined by the cut, clarity, size, and weight of the sapphires. Inventory consists of sapphire jewels that meet rigorous grading criteria and are of cuts and sizes most commonly used in the jewelry industry. As of December 31, 2021 and 2020, the Company carried primarily loose sapphire jewels, jewelry for sale on our website, and jewelry held as samples. Samples are used to show potential customers what the jewelry would look like. Promotional items given to customers that are not expected to be returned will be removed from inventory and expensed. There have been no promotional items given to customers as of December 31, 2021. The Company performs its own in-house assessment based on gem guide and the current market price for metals to value its inventory on an annual basis or if circumstances dictate sooner to determine if the estimated fair value is greater or less than cost. In addition, the inventory is reviewed each quarter by the Company against industry prices from gem-guide and if there is a potential impairment, the Company would appraise the inventory. The estimated fair value is subject to significant change due to changes in popularity of cut, perceived grade of the clarity of the sapphires, the number, type and size of inclusions, the availability of other similar quality and size sapphires, and other factors. As a result, the internal assessed value of the sapphires could be significantly lower from the current estimated fair value. Loose sapphire jewels do not degrade in quality over time. Based on the significant advancement of Sigyn Therapy, the Company decided in the 4th quarter of 2021 to assess the value of retail business operations that were a focus of the Company prior to the merger transaction consummated on October 19, 2020. Related to this assessment, management determined the wholesale liquidation value of its sapphire gem inventory to be 5-10% of the previously reported retail value, based on communications with certified gemologists, the variance between retail and wholesale valuations, and current market conditions. As a result, the Company has valued the inventory at $50,000 and recorded an impairment of assets of $536,047 in the year ended December 31, 2021 and is classified in other expenses in the consolidated Statements of Operations. Property and Equipment Property and equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets, generally five years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. Intangible Assets Intangible assets consist primarily of website development costs. Our intangible assets are being amortized on a straight-line basis over a period of three years. Assignment of Patent On January 8, 2020, James Joyce, the Company’s CEO and Craig Roberts, the Company’s CTO, assigned to the Company the rights to patent 62/881,740 pertaining to the devices, systems and methods for the broad-spectrum reduction of pro-inflammatory cytokines in blood in exchange for founder’s shares. Impairment of Long-lived Assets We periodically evaluate whether the carrying value of property, equipment and intangible assets has been impaired when circumstances indicate the carrying value of those assets may not be recoverable. The carrying amount is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying value is not recoverable, the impairment loss is measured as the excess of the asset’s carrying value over its fair value. Our impairment analysis requires management to apply judgment in estimating future cash flows as well as asset fair values, including forecasting useful lives of the assets, assessing the probability of different outcomes, and selecting the undiscounted rate that reflects the risk inherent in future cash flows. If the carrying value is not recoverable, we assess the fair value of long-lived assets using commonly accepted techniques, and may use more than one method, including, but not limited to, recent third-party comparable sales and discounted cash flow models. If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future. As of December 31, 2021 and 2020, the Company had not experienced impairment losses on its long-lived assets. Fair Value of Financial Instruments The provisions of accounting guidance, Financial Accounting Standards Board (“FASB”) Topic ASC 825, Financial Instruments – Overall, requires all entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value, and defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of December 31, 2021 and 2020, the fair value of cash, accounts payable, accrued expenses, and notes payable approximated carrying value due to the short maturity of the instruments, quoted market prices or interest rates which fluctuate with market rates. Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 1 – Quoted prices in active markets for identical assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities</td></tr></table> The carrying value of financial assets and liabilities recorded at fair value are measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels. Basic and Diluted Earnings Per Share Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted earnings (loss) per share are computed on the basis of the weighted average number of common shares (including common stock subject to redemption) plus dilutive potential common shares outstanding for the reporting period. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect. Stock-Based Compensation In accordance with ASC No. 718, Compensation – Stock Compensation (“ASC 718”), we measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant. Non-Employee Stock-Based Compensation In accordance with ASC 505, Equity Based Payments to Non-Employees, issuances of the Company’s common stock or warrants for acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently large disincentive for nonperformance) or (ii) the date at which performance is complete. Although situations may arise in which counter performance may be required over a period of time, the equity award granted to the party performing the service is fully vested and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist as the instruments fully vested on the date of agreement, the Company determines such date to be the measurement date and will record the estimated fair market value of the instruments granted as a prepaid expense and amortize such amount to general and administrative expense in the accompanying statement of operations over the contract period. When it is appropriate for the Company to recognize the cost of a transaction during financial reporting periods prior to the measurement date, for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values at each of those interim financial reporting dates. Reclassifications Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the Consolidated Statements of Operations for fiscal year ended December 31, 2020, to reclass $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zxBjtB0SQAnk" title="Research and development expense">391,906 of costs to research and development previously classified in general and administrative. Concentrations, Risks, and Uncertainties Business Risk Substantial business risks and uncertainties are inherent to an entity, including the potential risk of business failure. The Company is headquartered and operates in the United States. To date, the Company has generated no revenues from operations. There can be no assurance that the Company will be able to raise additional capital and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. Currently, these contingencies include general economic conditions, price of components, competition, and governmental and political conditions. Interest Rate Risk Financial assets and liabilities do not have material interest rate risk. Credit Risk The Company is exposed to credit risk from its cash in banks. The credit risk on cash in banks is limited because the counterparties are recognized financial institutions. Seasonality The business is not subject to substantial seasonal fluctuations. Major Suppliers Sigyn Therapy is comprised of components that are supplied by various industry vendors. Additionally, the Company is reliant on third-party organizations to conduct clinical development studies that are necessary to advance Sigyn Therapy toward the marketplace. Should the relationship with an industry vendor or third-party clinical development organization be interrupted or discontinued, it is believed that alternate component suppliers and third-party clinical development organizations could be identified to support the continued advancement of Sigyn Therapy. Recent Accounting Pronouncements In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurements (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. This standard removes, modifies, and adds certain disclosure requirements for fair value measurements. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU No. 2018-13 in the first quarter of fiscal 2020, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This standard aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company’s accounting for the service element of a hosting arrangement that is a service contract is not affected by the proposed amendments and will continue to be expensed as incurred in accordance with existing guidance. This standard does not expand on existing disclosure requirements except to require a description of the nature of hosting arrangements that are service contracts. This standard is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period for which financial statements have not been issued. Entities can choose to adopt the new guidance prospectively or retrospectively. The Company adopted the updated disclosure requirements of ASU No. 2018-15 prospectively in the first quarter of fiscal 2020, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes. This standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, Income Taxes, while also clarifying and amending existing guidance, including interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU No. 2019-12 in the first quarter of fiscal 2021, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In August 2020, the FASB issued ASU No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This ASU is effective for annual reporting periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. This update permits the use of either the modified retrospective or fully retrospective method of transition. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements and related disclosures. Other recently issued accounting updates are not expected to have a material impact on the Company’s consolidated financial statements.

Use of Estimates The preparation of these consolidated financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of net sales and expenses during the reported periods. Actual results may differ from those estimates and such differences may be material to the consolidated financial statements. The more significant estimates and assumptions by management include among others: realizability of inventory, common stock valuation, and the recoverability of intangibles. The current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.

Cash The Company’s cash is held in bank accounts in the United States and is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. The Company has not experienced any cash losses.

250000

Income Taxes Income taxes are accounted for under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Balance Sheets in accordance with Accounting Standards Codification (“ASC”) ASC 740, Income Taxes, which established financial accounting and reporting standards for the effect of income taxes. The likelihood that its deferred tax assets will be recovered from future taxable income must be assessed and, to the extent that recovery is not likely, a valuation allowance is established. Changes in the valuation allowance in a period are recorded through the income tax provision in the consolidated Statements of Operations. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s consolidated financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company does not have a liability for unrecognized income tax benefits.

less than a 50% likelihood

Advertising and Marketing Costs Advertising expenses are recorded as general and administrative expenses when they are incurred. The Company had no advertising expenses for year ended December 31, 2021 and had $705 for the year ended December 31, 2020.

705

Research and Development All research and development costs are expensed as incurred. The Company incurred research and development expense of $734,014 and $419,362 for the years ended December 31, 2021 and 2020, respectively.

734014

419362

Inventories In conjunction with the October 19, 2020 Share Exchange Agreement, the Company kept the gem inventory of Reign Resources Corporation. Inventories are stated at the lower of cost or market (net realizable value) on a lot basis each quarter. A lot is determined by the cut, clarity, size, and weight of the sapphires. Inventory consists of sapphire jewels that meet rigorous grading criteria and are of cuts and sizes most commonly used in the jewelry industry. As of December 31, 2021 and 2020, the Company carried primarily loose sapphire jewels, jewelry for sale on our website, and jewelry held as samples. Samples are used to show potential customers what the jewelry would look like. Promotional items given to customers that are not expected to be returned will be removed from inventory and expensed. There have been no promotional items given to customers as of December 31, 2021. The Company performs its own in-house assessment based on gem guide and the current market price for metals to value its inventory on an annual basis or if circumstances dictate sooner to determine if the estimated fair value is greater or less than cost. In addition, the inventory is reviewed each quarter by the Company against industry prices from gem-guide and if there is a potential impairment, the Company would appraise the inventory. The estimated fair value is subject to significant change due to changes in popularity of cut, perceived grade of the clarity of the sapphires, the number, type and size of inclusions, the availability of other similar quality and size sapphires, and other factors. As a result, the internal assessed value of the sapphires could be significantly lower from the current estimated fair value. Loose sapphire jewels do not degrade in quality over time. Based on the significant advancement of Sigyn Therapy, the Company decided in the 4th quarter of 2021 to assess the value of retail business operations that were a focus of the Company prior to the merger transaction consummated on October 19, 2020. Related to this assessment, management determined the wholesale liquidation value of its sapphire gem inventory to be 5-10% of the previously reported retail value, based on communications with certified gemologists, the variance between retail and wholesale valuations, and current market conditions. As a result, the Company has valued the inventory at $50,000 and recorded an impairment of assets of $536,047 in the year ended December 31, 2021 and is classified in other expenses in the consolidated Statements of Operations.

50000

536047

Property and Equipment Property and equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets, generally five years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

P5Y

Intangible Assets Intangible assets consist primarily of website development costs. Our intangible assets are being amortized on a straight-line basis over a period of three years. Assignment of Patent On January 8, 2020, James Joyce, the Company’s CEO and Craig Roberts, the Company’s CTO, assigned to the Company the rights to patent 62/881,740 pertaining to the devices, systems and methods for the broad-spectrum reduction of pro-inflammatory cytokines in blood in exchange for founder’s shares.

P3Y

Impairment of Long-lived Assets We periodically evaluate whether the carrying value of property, equipment and intangible assets has been impaired when circumstances indicate the carrying value of those assets may not be recoverable. The carrying amount is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying value is not recoverable, the impairment loss is measured as the excess of the asset’s carrying value over its fair value. Our impairment analysis requires management to apply judgment in estimating future cash flows as well as asset fair values, including forecasting useful lives of the assets, assessing the probability of different outcomes, and selecting the undiscounted rate that reflects the risk inherent in future cash flows. If the carrying value is not recoverable, we assess the fair value of long-lived assets using commonly accepted techniques, and may use more than one method, including, but not limited to, recent third-party comparable sales and discounted cash flow models. If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future. As of December 31, 2021 and 2020, the Company had not experienced impairment losses on its long-lived assets.

Fair Value of Financial Instruments The provisions of accounting guidance, Financial Accounting Standards Board (“FASB”) Topic ASC 825, Financial Instruments – Overall, requires all entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value, and defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of December 31, 2021 and 2020, the fair value of cash, accounts payable, accrued expenses, and notes payable approximated carrying value due to the short maturity of the instruments, quoted market prices or interest rates which fluctuate with market rates.

Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 1 – Quoted prices in active markets for identical assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities</td></tr></table> The carrying value of financial assets and liabilities recorded at fair value are measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels.

Basic and Diluted Earnings Per Share Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted earnings (loss) per share are computed on the basis of the weighted average number of common shares (including common stock subject to redemption) plus dilutive potential common shares outstanding for the reporting period. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect.

Stock-Based Compensation In accordance with ASC No. 718, Compensation – Stock Compensation (“ASC 718”), we measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Non-Employee Stock-Based Compensation In accordance with ASC 505, Equity Based Payments to Non-Employees, issuances of the Company’s common stock or warrants for acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently large disincentive for nonperformance) or (ii) the date at which performance is complete. Although situations may arise in which counter performance may be required over a period of time, the equity award granted to the party performing the service is fully vested and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist as the instruments fully vested on the date of agreement, the Company determines such date to be the measurement date and will record the estimated fair market value of the instruments granted as a prepaid expense and amortize such amount to general and administrative expense in the accompanying statement of operations over the contract period. When it is appropriate for the Company to recognize the cost of a transaction during financial reporting periods prior to the measurement date, for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values at each of those interim financial reporting dates.

Reclassifications Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the Consolidated Statements of Operations for fiscal year ended December 31, 2020, to reclass $<span id="xdx_90B_eus-gaap--ResearchAndDevelopmentExpense_c20200101__20201231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zxBjtB0SQAnk" title="Research and development expense">391,906 of costs to research and development previously classified in general and administrative.

391906

Concentrations, Risks, and Uncertainties Business Risk Substantial business risks and uncertainties are inherent to an entity, including the potential risk of business failure. The Company is headquartered and operates in the United States. To date, the Company has generated no revenues from operations. There can be no assurance that the Company will be able to raise additional capital and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. Currently, these contingencies include general economic conditions, price of components, competition, and governmental and political conditions. Interest Rate Risk Financial assets and liabilities do not have material interest rate risk. Credit Risk The Company is exposed to credit risk from its cash in banks. The credit risk on cash in banks is limited because the counterparties are recognized financial institutions. Seasonality The business is not subject to substantial seasonal fluctuations. Major Suppliers Sigyn Therapy is comprised of components that are supplied by various industry vendors. Additionally, the Company is reliant on third-party organizations to conduct clinical development studies that are necessary to advance Sigyn Therapy toward the marketplace. Should the relationship with an industry vendor or third-party clinical development organization be interrupted or discontinued, it is believed that alternate component suppliers and third-party clinical development organizations could be identified to support the continued advancement of Sigyn Therapy.

Recent Accounting Pronouncements In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurements (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement. This standard removes, modifies, and adds certain disclosure requirements for fair value measurements. This pronouncement is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. The Company adopted ASU No. 2018-13 in the first quarter of fiscal 2020, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract. This standard aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company’s accounting for the service element of a hosting arrangement that is a service contract is not affected by the proposed amendments and will continue to be expensed as incurred in accordance with existing guidance. This standard does not expand on existing disclosure requirements except to require a description of the nature of hosting arrangements that are service contracts. This standard is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, including adoption in any interim period for which financial statements have not been issued. Entities can choose to adopt the new guidance prospectively or retrospectively. The Company adopted the updated disclosure requirements of ASU No. 2018-15 prospectively in the first quarter of fiscal 2020, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes. This standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, Income Taxes, while also clarifying and amending existing guidance, including interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU No. 2019-12 in the first quarter of fiscal 2021, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In August 2020, the FASB issued ASU No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This ASU is effective for annual reporting periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. This update permits the use of either the modified retrospective or fully retrospective method of transition. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements and related disclosures. Other recently issued accounting updates are not expected to have a material impact on the Company’s consolidated financial statements.

NOTE 4 – EQUIPMENT PROPERTY AND EQUIPMENT Equipment consisted of the following as of: SCHEDULE OF PROPERTY AND EQUIPMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated Life</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 55%; text-align: justify">Office equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zs4TLTiDshWb" title="Estimated useful life">5 years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Equipment gross">28,181</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Equipment gross">1,787</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Computer equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zo2fbsAvKBy9" title="Estimated useful life">3 years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zXhDH7o9mlkj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equipment gross">3,157</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zx7EsJvxW8hc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equipment gross">287</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z0LKKuk8mzNj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(3,292</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zCb6wUcHK7Bf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(346</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zyON1F4FhPv" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">28,046</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_zClex8gm2pTd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">1,728</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> Depreciation expense was $2,946 and $346 for the years ended December 31, 2021 and 2020, respectively, and is classified in general and administrative expenses in the Consolidated Statements of Operations.

Equipment consisted of the following as of: SCHEDULE OF PROPERTY AND EQUIPMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated Life</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 55%; text-align: justify">Office equipment</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zs4TLTiDshWb" title="Estimated useful life">5 years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Equipment gross">28,181</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Equipment gross">1,787</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Computer equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zo2fbsAvKBy9" title="Estimated useful life">3 years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zXhDH7o9mlkj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equipment gross">3,157</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zx7EsJvxW8hc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Equipment gross">287</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z0LKKuk8mzNj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(3,292</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zCb6wUcHK7Bf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(346</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zyON1F4FhPv" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">28,046</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20201231_zClex8gm2pTd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">1,728</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

P5Y

28181

1787

P3Y

3157

287

3292

346

28046

1728

2946

346

NOTE 5 – INTANGIBLE ASSETS Intangible assets consisted of the following as of: SCHEDULE OF INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated life</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify">Trademarks</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center">3 years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zIE0dZCf6Xvf" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Intangible assets gross">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z681kEZDwLok" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Intangible assets gross">22,060</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Website</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3 years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_z7EM8qFpveaf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">10,799</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_z8zVAGJlvx52" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">10,799</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20211231_zOrLsQ9R9GE2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">(5,099</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20201231_zdF1fBSkDhYl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">(10,954</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20211231_zpBf6V2sRX42" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">5,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20201231_zpoRKPdpyMn3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">21,905</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> As of December 31, 2021, estimated future amortization expenses related to intangible assets were as follows: SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE RELATED TO INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_497_20211231_zdDC9I4YD8Sk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANz2CQ_z5NelCzqm2vk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">3,600</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANz2CQ_zu5YZQDkDmId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">2023</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz2CQ_z61Q64uJCpa7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> The Company had amortization expense of $16,205 and $10,954 for the years ended December 31, 2021 and 2020, respectively. On January 8, 2020, James Joyce, the Company’s CEO and Craig Roberts, the Company’s COO, assigned to the Company the rights to patent 62/881,740 pertaining to the devices, systems and methods for the broad-spectrum reduction of pro-inflammatory cytokines in blood.

Intangible assets consisted of the following as of: SCHEDULE OF INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Estimated life</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify">Trademarks</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center">3 years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zIE0dZCf6Xvf" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Intangible assets gross">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z681kEZDwLok" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Intangible assets gross">22,060</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Website</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3 years</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_z7EM8qFpveaf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">10,799</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--WebsiteMember_z8zVAGJlvx52" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">10,799</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20211231_zOrLsQ9R9GE2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">(5,099</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_c20201231_zdF1fBSkDhYl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">(10,954</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20211231_zpBf6V2sRX42" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">5,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_c20201231_zpoRKPdpyMn3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intangible assets gross">21,905</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

P3Y

22060

P3Y

10799

5099

10954

5700

21905

As of December 31, 2021, estimated future amortization expenses related to intangible assets were as follows: SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE RELATED TO INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_497_20211231_zdDC9I4YD8Sk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Intangible Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANz2CQ_z5NelCzqm2vk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">3,600</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANz2CQ_zu5YZQDkDmId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">2023</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANz2CQ_z61Q64uJCpa7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">5,700</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

3600

2100

5700

16205

10954

NOTE 6 – CONVERTIBLE PROMISSORY DEBENTURES Convertible notes payable consisted of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Total convertible notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_c20211231_zdvUR5hZZ97f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">700,816</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_c20201231_zJqn8fkF0Av2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">616,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">January 28, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z5D21q2lvFVk">457,380) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zc6TOkQVrWHe">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20200125__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zsUCkRCKtdak">October 20, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zsj6W1sXKG48" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Convertible notes payable">457,380</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z3KrFVRVwQb4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Convertible notes payable">385,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">June 23, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zO31BlT9opDg">60,500) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zRGDGtLbahkl">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20200620__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zhJuaaM3JdM4">October 20, 2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zzxgg5bg49Fe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">60,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zqa9Sye99CA2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">September 17, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zPWKJV8IzWD2">199,650) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zti85g9dsgJ2">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_z1sGes26sno">October 20, 2022. On October 28, 2021, Osher elected to convert $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zPlpaOMNvYBj">16,714 of the aggregate principal amount of the Note of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--DebtConversionOriginalDebtAmount1_dd_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zyOD504HrC5c">199,650, into <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_dd_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zVTwmMaYOKyi">42,857 common shares.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zYz8TJjHO8hh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">182,936</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zVek6WnuHKvf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">181,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Total convertible notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConvertibleNotesPayable_iI_c20211231_zsu2wOEgEeM3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">700,816</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_c20201231_zH0sQYqeEtw8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">616,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Original issue discount</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--DebtInstrumentOriginalDiscount_iI_c20211231_zHnr9aM46ECg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount">(53,614</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--DebtInstrumentOriginalDiscount_iI_c20201231_zAa2gQgJuV8j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount">(19,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Debt discount</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20211231_zLoVVccRVig5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20201231_zlO2UDiXJK3d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount">(78,165</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Total convertible notes payable</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20211231_z7QbD0aKadha" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total convertible notes payable">647,202</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20201231_z15VnKLIHHwh" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total convertible notes payable">518,668</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> Current Noteholders Osher – $457,380 On January 28, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of <span id="xdx_90C_eus-gaap--DebtConversionDescription_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zCCQjRPzpPP5" title="Debt conversion, description">(i) $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zJtj75QKFVSj" title="Aggregate principal amount of debt">385,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture due <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zpLXRf1QW448" title="Debt instrument maturity date">January 26, 2021, based on $1.00 for each $0.90909 paid by Osher and (ii) <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zAEOfaRrkpzl" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants to purchase up to an aggregate of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Aggregate number of warrants to purchase shares">80,209 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zys57SQNgs42" title="Exercise price of warrants per share">7.00 per share. The aggregate cash subscription amount received by the Company from Osher for the issuance of the note and warrants was $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z9tBDvHXecyd" title="Proceeds from issuance of convertible debt">350,005 which was issued at a $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zcAFHcsqNNGk" title="Original issue discount amount">34,995 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Debt instrument conversion price per share">0.094 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and Osher amended the convertible debt agreement as follow on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated January 28, 2020, for the number of warrant shares from <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zA8yWlnNmEA9">80,209 warrant shares to <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zTzDd8oClP5e" title="Aggregate number of warrants to purchase shares">4,113,083 warrant shares at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_z4rUFkzBXuG9" title="Exercise price of warrants per share">0.14 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note to provide for interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zxOC1JahodTg" title="Debt instrument interest rate stated percentage">8% per annum.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zjmqwXKjtQS3">maturity date from June 23, 2021 to October 20, 2021.</td></tr></table> On October 22, 2021, the Company and Osher amended convertible debt agreements as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDateDescription_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zGFLVY0DlZch">maturity date from October 20, 2021 to October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_c20211021__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zaanc1aiB749" title="Principal amount">652,300 to $<span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zCFkYA5P4Xsg" title="Principal amount">717,530 which is issued at a $<span id="xdx_90D_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zkQNjJ87Qu6d" title="Accrued interest">65,230 original issue discount from the face value of the October 20, 2020 Notes now due October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In exchange for the extension of the Note, the Company issued Osher <span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zfBKsgQFa5wg" title="Term of warrants::XDX::P5Y">five-year warrants to purchase an aggregate of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zVpQlSQVFpQc" title="Aggregate number of warrants to purchase shares">450,000 shares of the Company’s common stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zEFNH4slbdWd" title="Exercise price of warrants per share">1.00 per share.</td></tr> </table> Osher – $60,500 (as amended on October 20, 2020 to $55,000) On June 23, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of <span id="xdx_90D_eus-gaap--DebtConversionDescription_c20200621__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderOneMember" title="Debt conversion, description">(i) $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zJbm8DQtJBNa">50,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDate_c20200622__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zkUFlR1BNvGg">June 23, 2021, based on $1.00 for each $0.90909 paid by Osher and (ii) <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zOrh2EVmxPz2" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants”) to purchase up to an aggregate of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Aggregate number of warrants to purchase shares">10,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from Osher for the issuance of the Note and Warrants was $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20200621__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pp0p0" title="Proceeds from issuance of convertible debt">50,005 which was issued at a $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pp0p0" title="Original issue discount amount">0 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and Osher amended the convertible debt agreement as follow on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the aggregate principal amount from $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zATlH6Ou1HT1" title="Aggregate principal amount of debt">50,000 to $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zuONLDJtiRZ9" title="Aggregate principal amount of debt">55,000. The aggregate cash subscription amount received by the Company from Osher for the issuance of the Note and Warrants was $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_c20200621__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zW2D5AFkwzdl" title="Proceeds from issuance of convertible debt">50,005 which was issued at an amended $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_pp0p0" title="Original issue discount amount">4,995 original issue discount from the face value of the Note.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated June 23, 2020, for the number of warrant shares from <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zPR4ZgUbWwxh">10,000 warrant shares to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_pdd" title="Aggregate number of warrants to purchase shares">141,020 warrant shares at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_pdd" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20211018__20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zvHXzGteSyOj">maturity date from June 23, 2021 to October 20, 2021.</td></tr></table> On October 22, 2021, the Company and Osher amended convertible debt agreements as follows (see Note 12): <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDateDescription_c20211021__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zst9C68pURZg">maturity date from October 20, 2021 to October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $<span id="xdx_90B_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211021__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z0JOA3nz0rG" title="Principal amount">652,300 to $<span id="xdx_905_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zGs9LvmRxyS5" title="Principal amount">717,530 which is issued at a $<span id="xdx_902_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zyvMqdqvX9ph" title="Accrued interest">65,230 original issue discount from the face value of the October 20, 2020 Notes now due October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In exchange for the extension of the Note, the Company issued Osher <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zSIy7cuMIC73" title="Warrant term::XDX::P5Y">five-year warrants to purchase an aggregate of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zF9tgtLcoRAl" title="Number of securities called by warrants">450,000 shares of the Company’s common stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zhjmpZukiZKe" title="Exercise price">1.00 per share.</td></tr> </table> Osher – $199,650 On September 17, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of <span id="xdx_908_eus-gaap--DebtConversionDescription_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember" title="Debt conversion, description">(i) $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zaxXmZdhTwGb">181,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zrruGEAq9X0e" title="Debt instrument maturity date">September 30, 2021, based on $1.00 for each $0.90909 paid by Osher and (ii) <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zckQpX80MqBb" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Aggregate number of warrants to purchase shares">8,250 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from Osher for the issuance of the Note and Warrants was $<span id="xdx_904_eus-gaap--ProceedsFromConvertibleDebt_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zowURbz6Ddb6" title="Proceeds from issuance of convertible debt">165,000 which was issued at a $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zZfi8g5IJiZe" title="Original issue discount amount">16,500 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and Osher amended the convertible debt agreement as follow on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated September 17, 2020, for the number of warrant shares from <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z8hKL8r52uEj">8,250 warrant shares to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">465,366 warrant shares at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zqIHLopkPotk">maturity date from September 30, 2021 to October 20, 2021.</td></tr></table> On October 22, 2021, the Company and Osher amended convertible debt agreements as follows (see Note 12): <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDateDescription_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zXuqp3lPLGvk">maturity date from October 20, 2021 to October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $<span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211021__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zCx05hCWdGwj" title="Principal amount">652,300 to $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zRzbeh6Aeb27" title="Principal amount">717,530 which is issued at a $<span id="xdx_904_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zBJwm9qhr4T7" title="Accrued interest">65,230 original issue discount from the face value of the October 20, 2020 Notes now due October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In exchange for the extension of the Note, the Company issued Osher <span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zCtPuMqyDCMi" title="Term of warrants::XDX::P5Y">five-year warrants to purchase an aggregate of <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zKvjF8fuyJbf" title="Aggregate number of warrants to purchase shares">450,000 shares of the Company’s common stock at an exercise price of $<span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zgmItcwGKeR5" title="Exercise price of warrants per share">1.00 per share.</td></tr> </table> On October 28, 2021, Osher elected to convert $<span id="xdx_905_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z8Fcijjwo3Ch" title="Debt principal amount converted">16,714 of the aggregate principal amount of the Note of $<span id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_dd_c20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zC3gWGmY0FK2" title="Debt instrument carrying amount">199,650, into <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zpeitiNX60y1" title="Shares issued upon conversion of debt">42,857 common shares. Previous Noteholders Previous Noteholder – $50,000 (as amended on October 20, 2020 to $55,000) On June 23, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to a previous noteholder of <span id="xdx_901_eus-gaap--DebtConversionDescription_c20200621__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zMWu0TWkTIse" title="Debt conversion, description">(i) $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z10MBWqEZKcb">50,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20200621__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember" title="Debt instrument maturity date">June 23, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zyTLF04oXnTd" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zwdSEu1hJUr7" title="Aggregate number of warrants to purchase shares">10,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zhVWhnwgT4K" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pp0p0" title="Aggregate principal amount of debt">50,000 which was issued at a $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zCofDut8GKl4" title="Original issue discount amount">0 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zUvebSkzefaf" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and the previous noteholder amended the convertible debt agreement as follows on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the aggregate principal amount from $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zfq9jQB92YWk">50,000 to $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zK8O1RgwFL55" title="Aggregate principal amount of debt">55,000. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderOneMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zLXgZq5w9zb5" title="Proceeds from issuance of convertible debt">50,000 which was issued at an amended $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderOneMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zKJDS55Hv3ti" title="Original issue discount amount">5,000 original issue discount from the face value of the Note.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated June 23, 2020, for the number of warrant shares from <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zSbcH3fGNBs5">10,000 warrant shares to <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderOneMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_z6f9Cb6JVilb" title="Aggregate number of warrants to purchase shares">141,020 warrant shares at an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderOneMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zUEBz8Mvrr09" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderOneMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zitjNtzH6nu2">maturity date from June 23, 2021 to October 20, 2021.</td></tr></table> On December 2, 2020, the previous noteholder elected to convert the aggregate principal amount of the Note, $<span id="xdx_90F_eus-gaap--DebtInstrumentCarryingAmount_iI_dd_c20201202__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z80wMPrLJxke" title="Debt instrument carrying amount">55,000, into <span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20201202__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--PreviousNoteholderOneMember_zbGUmqs0Rglb" title="Aggregate principal amount of debt">141,020 common shares. Previous Noteholder - $25,000 (as amended on October 20, 2020 to $27,500) On August 18, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to a previous noteholder of <span id="xdx_90A_eus-gaap--DebtConversionDescription_c20200816__20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt conversion, description">(i) $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zsKpV18ToQeh">25,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20200816__20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt instrument maturity date">August 18, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zczTtKe1cfZ2" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">5,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_90A_eus-gaap--ProceedsFromConvertibleDebt_c20200816__20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">25,000 which was issued at a $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Original issue discount amount">0 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and the previous noteholder amended the convertible debt agreement as follows on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the aggregate principal amount from $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Aggregate principal amount of debt">25,000 to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pp0p0" title="Aggregate principal amount of debt">27,500. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_908_eus-gaap--ProceedsFromConvertibleDebt_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">25,000 which was issued at an amended $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pp0p0" title="Original issue discount amount">2,500 original issue discount from the face value of the Note.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated August 18, 2020, for the number of warrant shares from <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200818__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z0yto4An55Xe">5,000 warrant shares to <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">70,510 warrant shares at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zmlx1HioEBhl">maturity date from August 18, 2021 to October 20, 2021.</td></tr></table> On October 28, 2020, the previous noteholder elected to convert the aggregate principal amount of the Note, $<span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20201028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zgQFOMcZiMm5" title="Debt instrument carrying amount">27,500, into <span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20201028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pp0p0" title="Aggregate principal amount of debt">70,510 common shares. On February 19, 2021, the previous noteholder exercised the warrants pursuant to the cashless exercise provision of the warrant agreement into <span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210219__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderTwoMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6aPNZiYO1cd" title="Aggregate principal amount of debt">57,147 common shares. The common shares have not been issued as of March 14, 2022. Previous Noteholder – $93,500 On September 18, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to a previous noteholder of <span id="xdx_901_eus-gaap--DebtConversionDescription_c20200916__20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt conversion, description">(i) $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zeAJCthAMnx2">93,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20200916__20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt instrument maturity date">September 30, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBUeOYBzMk5a" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">4,250 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20200916__20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">85,000 which was issued at a $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Original issue discount amount">8,500 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and the previous noteholder amended the convertible debt agreement as follows on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated September 18, 2020, for the number of warrant shares from <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200918__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9e1loPC6Bf4" title="Aggregate number of warrants to purchase shares">4,250 warrant shares to <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zjYDudCYJrkf" title="Aggregate number of warrants to purchase shares">239,734 warrant shares at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zf2y9hdVsoag" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_z9zzccbGNx58">maturity date from September 30, 2021 to October 20, 2021.</td></tr></table> On December 2, 2020, the previous noteholder elected to convert the aggregate principal amount of the Note, $<span id="xdx_90B_eus-gaap--DebtInstrumentCarryingAmount_iI_c20201202__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zELPrKxSxi1h" title="Debt instrument carrying amount">93,500, into <span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20201202__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderThreeMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3DpY2HginX5" title="Aggregate principal amount of debt">239,734 common shares. Previous Noteholder - $165,000 On September 21, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to a previous noteholder of <span id="xdx_906_eus-gaap--DebtConversionDescription_c20200919__20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt conversion, description">(i) $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zbwJkOJWzR3j">165,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20200919__20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt instrument maturity date">September 30, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_ztzjdfqds2g6" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">7,500 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_901_eus-gaap--ProceedsFromConvertibleDebt_c20200919__20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">150,000 which was issued at a $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Original issue discount amount">15,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and the previous noteholder amended the convertible debt agreement as follow on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the number of shares from the Warrants dated September 21, 2020, for the number of warrant shares from <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200921__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgTRShEaXRK7" title="Aggregate number of warrants to purchase shares">7,500 warrant shares to <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zOChmcotCEB" title="Aggregate number of warrants to purchase shares">423,060 warrant shares at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zI5WvibVP9qh" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zpBdTdIbbu5l">maturity date from September 30, 2021 to October 20, 2021.</td></tr></table> On November 5, 2020, the previous noteholder elected to convert the aggregate principal amount of the Note, $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20201105__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zVgQFPLIkoTh" title="Debt instrument carrying amount">165,000, into <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211105__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zdaRZihVBkl6" title="Aggregate number of warrants to purchase shares">423,060 common shares. Previous Noteholder – $27,500 (as amended on October 20, 2020 to $22,000) On September 28, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to a previous noteholder of (<span id="xdx_908_eus-gaap--DebtConversionDescription_c20200926__20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt conversion, description">i) $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z9vs9w6KIQ9l">27,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20200926__20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt instrument maturity date">August 28, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zvROFTVuofh" title="Aggregate number of warrants to purchase shares">1,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20200926__20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zM0jjamkcpxj" title="Proceeds from issuance of convertible debt">20,000 which was issued at a $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Original issue discount amount">7,500 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zvOtavHcRwqh" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and the previous noteholder amended the convertible debt agreement as follows on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the aggregate principal amount from $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_c20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Aggregate principal amount of debt">27,500 to $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pp0p0" title="Aggregate principal amount of debt">22,000. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_c20200926__20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">20,000 which was issued at an amended $<span id="xdx_902_eus-gaap--DebtInstrumentUnamortizedDiscount_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pp0p0" title="Original issue discount amount">2,000 original issue discount from the face value of the Note.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated September 28, 2020, for the number of warrant shares from <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200928__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzdgrxKzStyh">1,000 warrant shares to <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">56,408 warrant shares at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDateDescription_c20211018__20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zkdhdVSQ1uja">maturity date from August 18, 2021 to October 20, 2021.</td></tr></table> On October 27, 2020, the previous noteholder elected to convert the aggregate principal amount of the Note, $<span id="xdx_905_eus-gaap--DebtInstrumentCarryingAmount_iI_c20201027__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_z3736DtSfBre">22,000, into <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201027__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhq205OkY2Yc" title="Aggregate principal amount of debt">56,408 common shares. Previous Noteholder – $33,000 On September 29, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to a previous noteholder of <span id="xdx_90B_eus-gaap--DebtConversionDescription_c20200926__20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt conversion, description">(i) $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zQBEz3pRbeMl">33,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDate_c20200926__20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zpTTghbFNeL1" title="Debt instrument maturity date">August 18, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z2kOkZr1kmug" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">1,500 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20200926__20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">30,000 which was issued at a $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Original issue discount amount">3,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and the previous noteholder amended the convertible debt agreement as follows on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated September 29, 2020, for the number of warrant shares from <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200929__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUqXjam2M58i" title="Aggregate number of warrants to purchase shares">1,500 warrant shares to <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">84,612 warrant shares at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_pdd" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_z7dQHscB7AG4">maturity date from August 18, 2021 to October 20, 2021.</td></tr></table> On October 26, 2020, the previous noteholder elected to convert the aggregate principal amount of the Note, $<span id="xdx_903_eus-gaap--DebtInstrumentCarryingAmount_iI_c20201026__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderFiveMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_z0oIoadaCMY6">33,000, into <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSixMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zKiPKg7FyFCb" title="Aggregate number of warrants to purchase shares">84,612 common shares. Previous Noteholder – $110,000 On February 10, 2021, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to a previous noteholder of <span id="xdx_90B_eus-gaap--DebtConversionDescription_c20210209__20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember" title="Debt conversion, description">(i) $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zvDFGROfZw2">110,000 aggregate principal amount of Note due <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20210209__20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember" title="Debt instrument maturity date">February 11, 2022 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zWdIHYbMCOug" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Aggregate number of warrants to purchase shares">157,143 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Exercise price of warrants per share">1.20 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_907_eus-gaap--ProceedsFromConvertibleDebt_c20210209__20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pp0p0" title="Proceeds from issuance of convertible debt">100,000 which was issued at a $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pp0p0" title="Original issue discount amount">10,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_pdd" title="Debt instrument conversion price per share">0.70 per share, subject to adjustment as provided therein, such as stock splits and stock dividends. On May 10, 2021, the previous noteholder elected to convert the aggregate principal amount of a $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zsod6um9f2Aj" title="Aggregate principal amount of debt">110,000 convertible note issued on February 10, 2021 into <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210510__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zShVPTY6258h" title="Aggregate number of warrants to purchase shares">157,143 shares of the Company’s common stock. Previous Noteholder – $55,000 On May 4, 2021, the Company repaid the aggregate principal amount of a $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20210504__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderEightMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zrcS57aLLuld" title="Aggregate principal amount of debt">55,000 convertible debenture that was entered into on April 7, 2021 with a previous noteholder. The note was a 10% Original Issue Discount Senior Convertible Debenture (the “Note”) which included a <span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20210504__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderEightMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zd6FEKmxXrE2" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrant (“Warrants’) to purchase up to an aggregate of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210504__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderEightMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">71,429 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210504__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderEightMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Exercise price of warrants per share">1.20 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_904_eus-gaap--ProceedsFromConvertibleDebt_c20210501__20210504__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderEightMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">50,000 which was issued at a $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210504__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderEightMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Original issue discount amount">5,000 original issue discount from the face value of the Note. Previous Noteholder – $110,000 On February 10, 2021, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to a previous noteholder of <span id="xdx_90B_eus-gaap--DebtConversionDescription_c20210208__20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt conversion, description">(i) $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember_z4QfZ0VNwXtl">110,000 aggregate principal amount of Note due <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20210208__20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember" title="Debt instrument maturity date">February 11, 2022 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Aggregate number of warrants to purchase shares">157,143 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Exercise price of warrants per share">1.20 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_907_eus-gaap--ProceedsFromConvertibleDebt_c20210208__20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Proceeds from issuance of convertible debt">100,000 which was issued at a $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pp0p0" title="Original issue discount amount">10,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20210210__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_pdd" title="Debt instrument conversion price per share">0.70 per share, subject to adjustment as provided therein, such as stock splits and stock dividends. On October 25, 2021, the previous noteholder elected to convert the aggregate principal amount of the Note, $<span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211025__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zD1gPlP5TAfd" title="Debt instrument carrying amount">110,000, into <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211025__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__srt--TitleOfIndividualAxis__custom--PreviousNoteholderSevenMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztU86VxKpxCl" title="Aggregate number of warrants to purchase shares">157,143 common shares.

Convertible notes payable consisted of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 30, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Total convertible notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_c20211231_zdvUR5hZZ97f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">700,816</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_c20201231_zJqn8fkF0Av2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">616,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">January 28, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z5D21q2lvFVk">457,380) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zc6TOkQVrWHe">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20200125__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zsUCkRCKtdak">October 20, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zsj6W1sXKG48" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Convertible notes payable">457,380</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayable_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z3KrFVRVwQb4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Convertible notes payable">385,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">June 23, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zO31BlT9opDg">60,500) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zRGDGtLbahkl">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--DebtInstrumentMaturityDate_dd_c20200620__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zhJuaaM3JdM4">October 20, 2022</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zzxgg5bg49Fe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">60,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zqa9Sye99CA2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">September 17, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zPWKJV8IzWD2">199,650) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zti85g9dsgJ2">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_z1sGes26sno">October 20, 2022. On October 28, 2021, Osher elected to convert $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zPlpaOMNvYBj">16,714 of the aggregate principal amount of the Note of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--DebtConversionOriginalDebtAmount1_dd_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zyOD504HrC5c">199,650, into <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_dd_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zVTwmMaYOKyi">42,857 common shares.</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zYz8TJjHO8hh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">182,936</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConvertibleNotesPayable_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zVek6WnuHKvf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">181,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Total convertible notes payable</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConvertibleNotesPayable_iI_c20211231_zsu2wOEgEeM3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">700,816</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_c20201231_zH0sQYqeEtw8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Convertible notes payable">616,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Original issue discount</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--DebtInstrumentOriginalDiscount_iI_c20211231_zHnr9aM46ECg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount">(53,614</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--DebtInstrumentOriginalDiscount_iI_c20201231_zAa2gQgJuV8j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Original issue discount">(19,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Debt discount</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20211231_zLoVVccRVig5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20201231_zlO2UDiXJK3d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount">(78,165</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify">Total convertible notes payable</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20211231_z7QbD0aKadha" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total convertible notes payable">647,202</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20201231_z15VnKLIHHwh" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total convertible notes payable">518,668</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

700816

616500

457380

2022-10-20

457380

385000

60500

2022-10-20

60500

50000

199650

2022-10-20

16714

199650

42857

182936

181500

700816

616500

-53614 -19667

78165

647202

518668

(i) $385,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture due January 26, 2021, based on $1.00 for each $0.90909 paid by Osher

385000

2021-01-26

80209

7.00

350005

34995

0.094

80209

4113083

0.14

0.08

maturity date from June 23, 2021 to October 20, 2021

maturity date from October 20, 2021 to October 20, 2022

652300

717530

65230

450000

1.00

(i) $50,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due June 23, 2021, based on $1.00 for each $0.90909 paid by Osher

50000

2021-06-23

10000

30.00

50005

0.39

50000

55000

50005

4995

10000

141020

0.59

maturity date from June 23, 2021 to October 20, 2021

maturity date from October 20, 2021 to October 20, 2022

652300

717530

65230

450000

1.00

(i) $181,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due September 30, 2021, based on $1.00 for each $0.90909 paid by Osher

181500

2021-09-30

8250

30.00

165000

16500

0.39

8250

465366

0.59

maturity date from September 30, 2021 to October 20, 2021

maturity date from October 20, 2021 to October 20, 2022

652300

717530

65230

450000

1.00

16714

199650

42857

(i) $50,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due June 23, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder

50000

2021-06-23

10000

30.00

50000

0.39

50000

55000

50000

5000

10000

141020

0.59

maturity date from June 23, 2021 to October 20, 2021

55000

141020

(i) $25,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due August 18, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder

25000

2021-08-18

5000

30.00

25000

0.39

25000

27500

25000

2500

5000

70510

0.59

maturity date from August 18, 2021 to October 20, 2021

27500

70510

57147

(i) $93,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due September 30, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder

93500

2021-09-30

4250

30.00

85000

8500

0.39

4250

239734

0.59

maturity date from September 30, 2021 to October 20, 2021

93500

239734

(i) $165,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due September 30, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder

165000

2021-09-30

7500

30.00

150000

15000

0.39

7500

423060

0.59

maturity date from September 30, 2021 to October 20, 2021

165000

423060

i) $27,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due August 28, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder

27500

2021-08-28

1000

30.00

20000

7500

0.39

27500

22000

20000

2000

1000

56408

0.59

maturity date from August 18, 2021 to October 20, 2021

22000

56408

(i) $33,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due August 18, 2021, based on $1.00 for each $0.90909 paid by the previous noteholder

33000

2021-08-18

1500

30.00

30000

3000

0.39

1500

84612

0.59

maturity date from August 18, 2021 to October 20, 2021

33000

84612

(i) $110,000 aggregate principal amount of Note due February 11, 2022 based on $1.00 for each $0.90909 paid by the previous noteholder

110000

2022-02-11

157143

1.20

100000

10000

0.70

110000

157143

55000

71429

1.20

50000

5000

(i) $110,000 aggregate principal amount of Note due February 11, 2022 based on $1.00 for each $0.90909 paid by the previous noteholder

110000

2022-02-11

157143

1.20

100000

10000

0.70

110000

157143

NOTE 7 – STOCKHOLDERS’ EQUITY STOCKHOLDERS’ DEFICIT The Company has authorized 1,000,000,000 shares of par value $0.0001 common stock, of which 37,295,803 shares are outstanding at December 31, 2021. Common Stock On October 28, 2021, Osher elected to convert $16,714 of the aggregate principal amount of the Note of $199,650, into <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211027__20211028__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zpL86qszTFZk" title="Shares issued upon conversion of debt">42,857 common shares. On October 25, 2021, Osher elected to convert the aggregate principal amount of the Note, $<span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_dd_c20211025__us-gaap--TypeOfArrangementAxis__custom--MarketingConsultingAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zfIpwbbaUPd7" title="Debt instrument carrying amount">110,000, into <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_dd_c20211024__20211025__us-gaap--TypeOfArrangementAxis__custom--MarketingConsultingAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zDIJJddI5Vq8" title="Shares issued upon conversion of debt">157,143 common shares. On October 20, 2021, the entered into a securities purchase agreement with an accredited investor that resulted in the issuance of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211018__20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zEYZgWzzt4bb" title="Stock issued during period value shares issues">320,000 shares of common stock and warrants to purchase an aggregate of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z28WXZyWmQef" title="Aggregate number of warrants to purchase shares">320,000 shares of the Company’s common stock for total proceeds totaling $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211008__20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zcjMgiEt6c75" title="Proceeds from issuance of common stock">400,000. <span id="xdx_90B_eus-gaap--DebtConversionDescription_c20211018__20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZmE0hF18jF4">The offering allowed for qualified investors to purchase one share of the Company’s common stock at $1.25. For each share purchased, the investor received a five-year warrant to purchase one share of common stock at $1.25 per share. No commissions were paid in the offering. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. On October 14, 2021, the Company issued a total of 47,000 shares of its common stock valued at $37,600 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for communications to the financial industry. On July 14, 2021, the Company issued a total of 47,000 shares of its common stock valued at $47,000 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for communications to the financial industry. On May 10, 2021, Brio Capital elected to convert the aggregate principal amount of a $110,000 convertible note issued on February 10, 2021 into 157,143 shares of the Company’s common stock. In April 2021, the Company initiated an offering of up to $1.5 million of the Company’s restricted common shares. The offering allowed for qualified investors to purchase one share of the Company’s common stock $1.25. For each share purchased, the investor received a five-year warrant to purchase one share of common stock at $1.75 per share. On May 10, 2021, the Company closed the offering to investors and subsequently disclosed that it had entered into securities purchase agreements with accredited investors that resulted in the issuance of 1,172,000 shares of common stock and warrants to purchase an aggregate of 1,172,000 shares of the Company’s common stock for total proceeds totaling $1,465,000. No commissions were paid in the offering. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. On April 14, 2021, the Company issued a total of 47,000 shares of its restricted common stock valued at $82,250 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for communications to the financial industry. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. On February 19, 2021, a previous noteholder exercised the warrants pursuant to the cashless exercise provision of the warrant agreement into <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210219__srt--TitleOfIndividualAxis__custom--PreviousNoteholderMember_zxbYu5kztHni" title="Aggregate numbers of warrants to purchase shares">57,147 common shares. The common shares have not been issued as of March 14, 2022. On January 14, 2021, the Company issued a total of 47,000 shares of its restricted common stock valued at $82,250 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for communications to the financial industry. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. During the year ended December 31, 2020, the Company issued 1,015,344 common shares to third parties in conjunction with the exchange of convertible promissory debentures. On October 19, 2020, the Company issued 33,686,169 common shares in conjunction with acquisition. Warrants On October 22, 2021, the Company and Osher amended convertible debt agreements for the maturity date from October 20, 2021 to October 20, 2022. In exchange for the extension of the Note, the Company issued Osher <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211018__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zZlwudu7NGWb" title="Stock issued during period shares">450,000 warrants to purchase an aggregate of 450,000 shares of the Company’s common stock, valued at $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211018__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_ztG0EbRjLKic" title="Proceeds from issuance of common stock">197,501 (based on the Black Scholes valuation model on the date of grant) (see Note 6). The warrants are exercisable for a period of five years at $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zS6HRjhVczsd" title="Exercise price of warrants per share">1.00 per share in whole or in part, as either a cash exercise or as a cashless exercise, and fully vest at grant date. The Company is amortizing the value of the warrants ratably through October 20, 2022. The Company recorded $40,041 and $0 for the years ended December 31, 2021 and 2020, respectively, and is classified in other expenses in the consolidated Statements of Operations.

1000000000

0.0001

37295803

16714

199650

42857

110000

157143

320000

400000

The offering allowed for qualified investors to purchase one share of the Company’s common stock at $1.25. For each share purchased, the investor received a five-year warrant to purchase one share of common stock at $1.25 per share. No commissions were paid in the offering. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration.

47000

37600

47000

110000

157143

1500000

The offering allowed for qualified investors to purchase one share of the Company’s common stock $1.25. For each share purchased, the investor received a five-year warrant to purchase one share of common stock at $1.75 per share

1.25

1172000

1465000

47000

82250

57147

47000

82250

1015344

33686169

2022-10-20

450000

197501

P5Y

1.00

40041

NOTE 8 – OPERATING LEASES On May 27, 2021, the Company entered into a sixty-three month lease for its corporate office at $5,955 per month commencing June 15, 2021 maturing September 30, 2026. The Company accounts for this lease in accordance with ASC 842. Adoption of the standard resulted in the initial recognition of operating lease ROU asset of $290,827 and operating lease liability of $290,827 as of June 15, 2021. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives. Our variable lease payments primarily consist of maintenance and other operating expenses from our real estate leases. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have lease agreements with lease and non-lease components. We have elected to account for these lease and non-lease components as a single lease component. We are also electing not to apply the recognition requirements to short-term leases of twelve months or less and instead will recognize lease payments as expense on a straight-line basis over the lease term. The components of lease expense and supplemental cash flow information related to leases for the period are as follows: In accordance with ASC 842, the components of lease expense were as follows: SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Operating lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseExpense_c20210101__20211231_z5WDFaPkAlfi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating lease expense">41,811</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseExpense_c20200101__20201231_zW9ODkm1kXDh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating lease expense">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Short term lease cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortTermLeaseCost_c20210101__20211231_ztnvRgijiZI5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term lease cost">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortTermLeaseCost_c20200101__20201231_zgHS1icNWUp5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term lease cost">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total lease expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseCost_c20210101__20211231_zEgq1Yax5P3e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total lease expense">41,811</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseCost_d0_c20200101__20201231_zZefUuE5xkel" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total lease expense">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> In accordance with ASC 842, other information related to leases was as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Years ended December 31,</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Operating cash flows from operating leases</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeasePayments_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating cash flows from operating leases">17,866</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeasePayments_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating cash flows from operating leases">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Cash paid for amounts included in the measurement of lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">17,866</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Weighted-average remaining lease term—operating leases</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4.67 years </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Weighted-average discount rate—operating leases</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> In accordance with ASC 842, maturities of operating lease liabilities as of December 31, 2021 were as follows: SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Operating</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Year ending:</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Lease</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 78%; text-align: justify">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20211231_zO1P3dVtQog8" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="2022">72,714</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2023</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20211231_z20jWdjoATh7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="2023">74,895</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2024</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20211231_zDkXBc9PafSa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="2024">77,142</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2025</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20211231_zDqDlwNphczc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="2025">79,456</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20211231_zOt9dv8IXCnc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="2025">54,225</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total undiscounted cash flows</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_c20211231_zvx5f7fn53Rd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total undiscounted cash flows">358,431</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Reconciliation of lease liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Weighted-average remaining lease terms</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4.67 years </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Weighted-average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Present values</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--LeaseLiabilityPresentValues_iI_c20211231_z90qZ9DXX87a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Present values">286,716</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Lease liabilities—current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maNVN_c20211231_zDHvspmMSCsd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities - current">46,091</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Lease liabilities—long-term</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_pp0p0_maNVN_c20211231_zFGD9DioU8g9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities - long-term">240,625</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Lease liabilities—total</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_iTI_mtNVN_c20211231_zopexUr0Ge56" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities - total">286,716</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Difference between undiscounted and discounted cash flows</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20211231_z6rm5flxsXT7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Difference between undiscounted and discounted cash flows">71,715</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> Operating lease cost was $41,811 and $0 for the years ended December 31, 2021 and 2020, respectively.

5955

2026-09-30

290827

The components of lease expense and supplemental cash flow information related to leases for the period are as follows: In accordance with ASC 842, the components of lease expense were as follows: SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Years ended December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Operating lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseExpense_c20210101__20211231_z5WDFaPkAlfi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating lease expense">41,811</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseExpense_c20200101__20201231_zW9ODkm1kXDh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating lease expense">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Short term lease cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShortTermLeaseCost_c20210101__20211231_ztnvRgijiZI5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term lease cost">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortTermLeaseCost_c20200101__20201231_zgHS1icNWUp5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Short term lease cost">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total lease expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingLeaseCost_c20210101__20211231_zEgq1Yax5P3e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total lease expense">41,811</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseCost_d0_c20200101__20201231_zZefUuE5xkel" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total lease expense">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> In accordance with ASC 842, other information related to leases was as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Years ended December 31,</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: italic bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Operating cash flows from operating leases</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeasePayments_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating cash flows from operating leases">17,866</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeasePayments_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Operating cash flows from operating leases">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Cash paid for amounts included in the measurement of lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">17,866</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Weighted-average remaining lease term—operating leases</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4.67 years </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Weighted-average discount rate—operating leases</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

41811

-0

17866

P4Y8M1D

0.10

In accordance with ASC 842, maturities of operating lease liabilities as of December 31, 2021 were as follows: SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Operating</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: italic bold 10pt Times New Roman, Times, Serif; text-align: justify">Year ending:</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Lease</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 78%; text-align: justify">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_c20211231_zO1P3dVtQog8" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="2022">72,714</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2023</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_c20211231_z20jWdjoATh7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="2023">74,895</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2024</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_c20211231_zDkXBc9PafSa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="2024">77,142</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2025</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_c20211231_zDqDlwNphczc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="2025">79,456</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_c20211231_zOt9dv8IXCnc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="2025">54,225</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Total undiscounted cash flows</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_c20211231_zvx5f7fn53Rd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total undiscounted cash flows">358,431</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Reconciliation of lease liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Weighted-average remaining lease terms</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> 4.67 years </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Weighted-average discount rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Present values</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--LeaseLiabilityPresentValues_iI_c20211231_z90qZ9DXX87a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Present values">286,716</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Lease liabilities—current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maNVN_c20211231_zDHvspmMSCsd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities - current">46,091</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Lease liabilities—long-term</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_pp0p0_maNVN_c20211231_zFGD9DioU8g9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities - long-term">240,625</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Lease liabilities—total</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseLiability_iTI_mtNVN_c20211231_zopexUr0Ge56" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Lease liabilities - total">286,716</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Difference between undiscounted and discounted cash flows</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pp0p0_c20211231_z6rm5flxsXT7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Difference between undiscounted and discounted cash flows">71,715</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> Operating lease cost was $41,811 and $0 for the years ended December 31, 2021 and 2020, respectively.

72714

74895

77142

79456

54225

358431

P4Y8M1D

0.10

286716

46091

240625

286716

71715

41811

NOTE 9 – RELATED PARTY TRANSACTIONS Other than as set forth below, and as disclosed in Notes 5 and 7, there have not been any transaction entered into or been a participant in which a related person had or will have a direct or indirect material interest. Employment Agreements Mr. Joyce receives an annual base salary of $<span id="xdx_900_eus-gaap--OfficersCompensation_pp0p0_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_znjFXpxasLK3" title="Annual base salary">455,000, plus bonus compensation not to exceed <span id="xdx_901_ecustom--MaximumBonusCompensationPercentage_pid_dp_uPure_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_zEJ9Z6zu9GAk" title="Maximum bonus compensation percentage">50% of salary. Mr. Joyce’s employment also provides for medical insurance, disability benefits and one year of severance pay if his employment is terminated without cause or due to a change in control. Additionally, the Company has agreed to maintain a beneficial ownership target of <span id="xdx_900_ecustom--BeneficialOwnershipTargetPercentage_pid_dp_uPure_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_zoVzSq5RI7Di" title="Beneficial ownership target percentage">9% for Mr. Joyce. Mr. Joyce’s compensation was approved by the Reign Resources Corporation Board of Directors on October 6, 2020 and was among conditions of the Share Exchange Agreement that was completed with Sigyn Therapeutics, Inc. on October 19, 2020. The Company incurred compensation expense of $<span id="xdx_909_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_z8YMmFmHGHc4" title="Compensation expense">496,125 (including $<span id="xdx_905_eus-gaap--AccruedPayrollTaxesCurrent_iI_c20201231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_zXM0ccxZR50j">18,542 of 2020 payroll paid in 2021) and $<span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_zUkuhq1f3Ur3">418,842, and employee benefits of $<span id="xdx_90A_eus-gaap--PensionAndOtherPostretirementBenefitExpense_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChiefTechnologyOfficerMember_zZZHhsboFr6c" title="Employee benefits">31,126 and $<span id="xdx_90A_eus-gaap--PensionAndOtherPostretirementBenefitExpense_pp0p0_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChiefTechnologyOfficerMember_zJSa1RSjG95l">22,516, for the years ended December 31, 2021 and 2020, respectively. Sigyn had no employment agreement with its CTO but still incurred compensation on behalf of the CTO. The Company incurred compensation expense of $<span id="xdx_90D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChiefTechnologyOfficerMember_zVi4TXsvKG51" title="Compensation expense">259,000 and $<span id="xdx_90E_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChiefTechnologyOfficerMember_zYHVoPJgpBme" title="Compensation expense">233,981, and employee benefits of $<span id="xdx_903_eus-gaap--PensionAndOtherPostretirementBenefitExpense_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_zVUqjQg1bRf2" title="Employee benefits">21,704 and $<span id="xdx_906_eus-gaap--PensionAndOtherPostretirementBenefitExpense_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrJoyceMember_zwP6UQOhXcgb" title="Employee benefits">22,024, for the years ended December 31, 2021 and 2020, respectively. Bonus On July 21, 2021, as a result of achieving certain milestones, the Board of Directors agreed to pay each of the Company’s CEO and CTO a performance bonus equal to 5% of their annual salary totaling $34,750.

455000

0.50 0.09

496125

18542

418842

31126

22516

259000

233981

21704

22024

0.05

34750

NOTE 10 – INCOME TAXES At December 31, 2021, net operating loss carry forwards for Federal and state income tax purposes totaling approximately $1,408,000 available to reduce future income which under the Tax Cuts and Jobs Act of 2018, allows for an indefinite carryforward period, with carryforwards limited to 80% of each subsequent year’s net income. There is no income tax affect due to the recognition of a full valuation allowance on the expected tax benefits of future loss carry forwards based on uncertainty surrounding realization of such assets. A reconciliation of the statutory income tax rates and the effective tax rate is as follows: SCHEDULE OF RECONCILIATION OF STATUTORY INCOME TAX RATES AND EFFECTIVE TAX RATE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Statutory U.S. federal rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State income tax, net of federal benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(28.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(28.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">Provision for income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> The tax effects of the temporary differences and carry forwards that give rise to deferred tax assets consist of the following: SCHEDULE OF DEFERRED TAX ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49C_20211231_zxQm7y5qXdn8" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49F_20201231_zFG1lwX9tK64" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTALNzShF_zXtFMNWZHL0g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Net operating loss carry forwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">1,073,527</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">352,912</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNzShF_zDG2RrTuPrf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,073,527</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,912</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzShF_zZXbRv2qcjkj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Total</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> Major tax jurisdictions are the United States and California. All of the tax years will remain open three and four years for examination by the Federal and state tax authorities, respectively, from the date of utilization of the net operating loss. There are no tax audits pending.

1408000

0.80

A reconciliation of the statutory income tax rates and the effective tax rate is as follows: SCHEDULE OF RECONCILIATION OF STATUTORY INCOME TAX RATES AND EFFECTIVE TAX RATE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Statutory U.S. federal rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State income tax, net of federal benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(28.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(28.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">Provision for income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td></tr> </table>

0.210

0.070

0.000

-0.280

0.000

The tax effects of the temporary differences and carry forwards that give rise to deferred tax assets consist of the following: SCHEDULE OF DEFERRED TAX ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49C_20211231_zxQm7y5qXdn8" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49F_20201231_zFG1lwX9tK64" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTALNzShF_zXtFMNWZHL0g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Net operating loss carry forwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">1,073,527</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">352,912</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTALNzShF_zDG2RrTuPrf2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,073,527</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(352,912</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_mtDTALNzShF_zZXbRv2qcjkj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Total</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>

1073527

352912

1073527

352912

NOTE 11 – EARNINGS PER SHARE FASB ASC Topic 260, Earnings Per Share, requires a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share (EPS) computations. Basic earnings (loss) per share are computed by dividing net earnings available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect. The following table sets forth the computation of basic and diluted net income per share: SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years Ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Net loss attributable to the common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net loss attributable to the common stockholders">(3,004,619</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net loss attributable to the common stockholders">(1,259,590</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Basic weighted average outstanding shares of common stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic weighted average outstanding shares of common stock">36,396,585</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200101__20201231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic weighted average outstanding shares of common stock">7,351,272</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Dilutive effect of options and warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Dilutive effect of options and warrants">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c20200101__20201231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Dilutive effect of options and warrants">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Diluted weighted average common stock and common stock equivalents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Diluted weighted average common stock and common stock equivalents">36,396,585</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200101__20201231_zoNt1TZcwVa2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Diluted weighted average common stock and common stock equivalents">7,351,272</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Loss per share:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_c20210101__20211231_z9MY92ku2k84" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic and diluted">(0.08</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--EarningsPerShareBasic_pid_c20200101__20201231_zC8IXap5tCAl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic and diluted">(0.17</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table>

The following table sets forth the computation of basic and diluted net income per share: SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Years Ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Net loss attributable to the common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--NetIncomeLoss_c20210101__20211231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net loss attributable to the common stockholders">(3,004,619</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Net loss attributable to the common stockholders">(1,259,590</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Basic weighted average outstanding shares of common stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20210101__20211231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic weighted average outstanding shares of common stock">36,396,585</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20200101__20201231_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic weighted average outstanding shares of common stock">7,351,272</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Dilutive effect of options and warrants</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Dilutive effect of options and warrants">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c20200101__20201231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Dilutive effect of options and warrants">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Diluted weighted average common stock and common stock equivalents</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Diluted weighted average common stock and common stock equivalents">36,396,585</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20200101__20201231_zoNt1TZcwVa2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Diluted weighted average common stock and common stock equivalents">7,351,272</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Loss per share:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Basic and diluted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--EarningsPerShareBasic_pid_c20210101__20211231_z9MY92ku2k84" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic and diluted">(0.08</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--EarningsPerShareBasic_pid_c20200101__20201231_zC8IXap5tCAl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Basic and diluted">(0.17</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table>

-3004619

-1259590

36396585

7351272

36396585

7351272

-0.08

-0.17

NOTE 12 – COMMITMENTS AND CONTINGENCIES Legal From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any legal proceedings or claims that it believes will have a material adverse effect on its business, financial condition or operating results.

NOTE 13 – SUBSEQUENT EVENTS The Company evaluated all events or transactions that occurred after December 31, 2020 up through the date the financial statements were available to be issued. During this period, the Company did not have any material recognizable subsequent events required to be disclosed as of and for the period ended December 31, 2020 except for the following: Mr. Ferrell was hired March 9, 2022 as the Company’s Chief Financial Officer. Mr. Ferrell receives an annual base salary of $250,000, plus discretionary bonus compensation not to exceed 40% of salary. Mr. Ferrell’s employment also provides for medical insurance, disability benefits and three months of severance pay if his employment is terminated without cause or due to a change in control. Additionally, Mr. Ferrell will be granted up to <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220308__20220309__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zG5soxPyQdr2" title="Share based payment award options grants in period gross">600,000 options to purchase <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_c20220308__20220309__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zoZaIs5Nz4fg" title="Share based payment award shares purchased for award">600,000 of the Company’s common shares upon the implementation of a Company employee option plan. Convertible Promissory Debentures Osher – $110,000 On March 23, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of (i) $110,000 aggregate principal amount of Note due March 23, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of 220,000 shares of the Company’s Common Stock at an exercise price of $0.50 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $100,000 which was issued at a $10,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $0.50 per share, subject to adjustment as provided therein, such as stock splits and stock dividends. Brio – $110,000 On March 23, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Brio Capital Master Fund Ltd. (“Brio”) of (i) $110,000 aggregate principal amount of Note due March 23, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of 220,000 shares of the Company’s Common Stock at an exercise price of $0.50 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $100,000 which was issued at a $10,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $0.50 per share, subject to adjustment as provided therein, such as stock splits and stock dividends.

250000

0.40

600000

81385

340956

50000

12245

2075

143630

393031

26342

28046

4800

5700

251931

262771

20711

447414

710259

196147

39674

215896

53614

704920

647202

47794

46091

1987 1251

179

950848

734218

228135

240625

228135

240625

1178983

974843

0.0001

1000000000

37295803

3730

4208506

3997445

-4943805

-4265759

-731569

-264584

447414

710259

250

82250

228342

116516

380644

203330

609236

402096

-609236

-402096

52257 50860

16522

8726

-68810

-59586

-678046

-461682

-678046

-461682

-0.02

-0.01

37295803

35266601

35201513

3520

1356799

-1261140

99179

47000

82245

82250

113910

86090

57147 6 -6

-461682

35305660

3531

1639038

-1722822

-80253

37295803

3730

3997445

-4265759

-264584

162362

48699 48699

-678046

37295803

3730

4208506

-4943805

-731569

-678046

-461682

1704

344

900

10354

82250

-52257 -50860 16522 8726

10170

156473

28055

5007

789

1662

-459571

-274424

2871

-2871

200000

-259571

-77295

340956

84402

81385

7107

86090 48699 162362 113910

20000

85495

NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES Corporate History and Background Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our business focus is the clinical advancement of Sigyn Therapy™, a multi-function blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the leading cause of hospital deaths worldwide. We are advancing Sigyn Therapy to treat pathogen-associated conditions that precipitate sepsis and other high-mortality disorders that are not addressed with approved drug therapies. To address these unmet therapeutic needs, we designed Sigyn Therapy to extract pathogen sources of life-threating inflammation from the bloodstream in concert with the depletion of pro-inflammatory cytokines, whose dysregulated production (the cytokine storm) plays a prominent role in each of our therapeutic indication opportunities. In addition to sepsis, our candidate treatment indications include, but are not limited to; emerging pandemic threats, drug resistant pathogens, hepatic encephalopathy, bridge to liver transplant, and community-acquired pneumonia, which is a leading cause of death among infectious diseases, the leading cause of death in children under five years of age, and a catalyst for approximately 50% of sepsis and septic shock cases. Merger Transaction On October 19, 2020, Sigyn Therapeutics, Inc, a Delaware corporation (the “Registrant”) formerly known as Reign Resources Corporation, completed a Share Exchange Agreement (the “Agreement”) with Sigyn Therapeutics, Inc., a private entity incorporated in the State of Delaware on October 19, 2019. In the Share Exchange Agreement, we acquired <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20201019__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zKzt5wHzl1b" title="Percentage of acquisition ownership interest">100% of the issued and outstanding shares of privately held Sigyn Therapeutics common stock in exchange for <span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_uPure_c20201018__20201019__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zJiyChosquJf" title="Percentage of common stock outstanding">75% of the fully paid and nonassessable shares of our common stock outstanding (the “Acquisition”). In conjunction with the transaction, we changed our name from Reign Resources Corporation to Sigyn Therapeutics, Inc. pursuant to an amendment to our articles of incorporation that was filed with the State of Delaware. Subsequently, our trading symbol was changed to SIGY. The Acquisition was treated as a “tax-free exchange” under Section 368 of the Internal Revenue Code of 1986 and resulted in the private Sigyn Therapeutics corporate entity becoming a wholly owned subsidiary known as Sigyn Medical Corporation. Upon the closing of the Acquisition, we appointed James A. Joyce and Craig P. Roberts to serve as members of our Board of Directors. As of May 13, 2022, we have a total 37,295,803 shares issued and outstanding, of which <span id="xdx_900_ecustom--CommonStockSharesHeld_iI_c20220513__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--NonAffiliateShareholdersMember_z4fvm8RGnVA7" title="Common stock, shares held">11,655,803 shares are held by non-affiliate stockholders. Post Merger Developments Since the consummation of our public merger on October 19, 2020, we advanced Sigyn Therapy from conceptual design to clinical application. We initiated and completed several in vitro studies that validated the ability of Sigyn Therapy to address a broad-spectrum of relevant therapeutic targets, including endotoxin (gram-negative bacterial toxin); peptidoglycan and lipoteichoic acid (gram-positive bacterial toxins); viral pathogens (including SARS-CoV-2); hepatic toxins (ammonia, bile acid, and bilirubin); CytoVesicles (extracellular vesicles that transport inflammatory cytokine cargos); and tumor necrosis factor alpha (TNF alpha), interleukin-1 beta (IL-1b), and interleukin 6 (IL-6), which are pro-inflammatory cytokines whose dysregulated production (the cytokine storm) precipitate sepsis and play a prominent role in each of our therapeutic opportunities. Subsequent to these in vitro milestones, we completed animal studies that demonstrated Sigyn Therapy to be safe and well tolerated. We plan to incorporate the data collected from our post-merger studies into an Investigational Device Exemption (IDE) that we are drafting for submission to the U.S. Food and Drug Administration (“FDA”) to support the initiation of human clinical studies in the United States.

0.50

0.75

37295803

11655803

NOTE 2 – BASIS OF PRESENTATION The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and include all adjustments necessary for the fair presentation of the Company’s financial position and results of operations for the periods presented. The Company currently operates in one business segment. The Company is not organized by market and is managed and operated as one business. A single management team reports to the chief operating decision maker, the Chief Executive Officer, who comprehensively manages the entire business. The Company does not currently operate any separate lines of businesses or separate business entities. Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $4,943,805 at March 31, 2022, had a working capital deficit of $807,218 and $341,187 at March 31, 2022 and December 31, 2021, respectively, had a net loss of $678,046 and $461,682 for the three months ended March 31, 2022 and 2021, respectively, and net cash used in operating activities of $459,571 and $274,424 for the three months ended March 31, 2022 and 2021, respectively, with no revenue earned since inception, and a lack of operational history. These matters raise substantial doubt about the Company’s ability to continue as a going concern. While the Company is attempting to expand operations and increase revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management intends to raise additional funds by way of a private offering or an asset sale transaction. Management believes that the actions presently being taken to further implement its business plan and generate revenues provide the opportunity for the Company to continue as a going concern. While management believes in the viability of its strategy to generate revenues and in its ability to raise additional funds or transact an asset sale, there can be no assurances to that effect or on terms acceptable to the Company. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

-4943805

807218 341187

-678046

-461682

-459571

-274424

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to GAAP and have been consistently applied in the preparation of the financial statements. Use of Estimates The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Actual results may differ from those estimates and such differences may be material to the financial statements. The more significant estimates and assumptions by management include among others: common stock valuation, and the recoverability of intangibles. The current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions. Cash The Company’s cash is held in bank accounts in the United States and is insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. The Company has not experienced any cash losses. Income Taxes Income taxes are accounted for under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Balance Sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The likelihood that its deferred tax assets will be recovered from future taxable income must be assessed and, to the extent that recovery is not likely, a valuation allowance is established. Changes in the valuation allowance in a period are recorded through the income tax provision in the consolidated Statements of Operations. ASC 740-10-30 was adopted from the date of its inception. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s consolidated financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10 and currently, the Company does not have a liability for unrecognized income tax benefits. Advertising and Marketing Costs Advertising expenses are recorded as general and administrative expenses when they are incurred. The Company had advertising expenses of $250 and $82,250 for the three months ended March 31, 2022 and 2021, respectively. Inventories In conjunction with the October 19, 2020 Share Exchange Agreement, the Company kept the gem inventory of Reign Resources Corporation. Inventories are stated at the lower of cost or market (net realizable value) on a lot basis each quarter. A lot is determined by the cut, clarity, size, and weight of the sapphires. Inventory consists of sapphire jewels that meet rigorous grading criteria and are of cuts and sizes most commonly used in the jewelry industry. As of March 31, 2022 and December 31, 2021, the Company carried primarily loose sapphire jewels, jewelry for sale on our website, and jewelry held as samples. Samples are used to show potential customers what the jewelry would look like. Promotional items given to customers that are not expected to be returned will be removed from inventory and expensed. There have been no promotional items given to customers as of March 31, 2022. The Company performs its own in-house assessment based on gem guide and the current market price for metals to value its inventory on an annual basis or if circumstances dictate sooner to determine if the estimated fair value is greater or less than cost. In addition, the inventory is reviewed each quarter by the Company against industry prices from gem-guide and if there is a potential impairment, the Company would appraise the inventory. The estimated fair value is subject to significant change due to changes in popularity of cut, perceived grade of the clarity of the sapphires, the number, type and size of inclusions, the availability of other similar quality and size sapphires, and other factors. As a result, the internal assessed value of the sapphires could be significantly lower from the current estimated fair value. Loose sapphire jewels do not degrade in quality over time. Based on the significant advancement of Sigyn Therapy, the Company decided in the 4th quarter of 2021 to assess the value of retail business operations that were a focus of the Company prior to the merger transaction consummated on October 19, 2020. Related to this assessment, management determined the wholesale liquidation value of its sapphire gem inventory to be 5-10% of the previously reported retail value, based on communications with certified gemologists, the variance between retail and wholesale valuations, and current market conditions. As a result, the Company has valued the inventory at $50,000 and recorded an impairment of assets of $536,047 in the year ended December 31, 2021. Property and Equipment Property and equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets, generally five years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. Intangible Assets Intangible assets consist primarily of website development costs. Our intangible assets are being amortized on a straight-line basis over a period of three years. Impairment of Long-lived Assets We periodically evaluate whether the carrying value of property, equipment and intangible assets has been impaired when circumstances indicate the carrying value of those assets may not be recoverable. The carrying amount is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying value is not recoverable, the impairment loss is measured as the excess of the asset’s carrying value over its fair value. Our impairment analyses require management to apply judgment in estimating future cash flows as well as asset fair values, including forecasting useful lives of the assets, assessing the probability of different outcomes, and selecting the discount rate that reflects the risk inherent in future cash flows. If the carrying value is not recoverable, we assess the fair value of long-lived assets using commonly accepted techniques, and may use more than one method, including, but not limited to, recent third-party comparable sales and discounted cash flow models. If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future. As of March 31, 2022 and December 31, 2021, the Company had not experienced impairment losses on its long-lived assets. Fair Value of Financial Instruments The provisions of accounting guidance, FASB Topic ASC 825 requires all entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value, and defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of March 31, 2022 and December 31, 2021, the fair value of cash, accounts payable, accrued expenses, and notes payable approximated carrying value due to the short maturity of the instruments, quoted market prices or interest rates which fluctuate with market rates. Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 1 – Quoted prices in active markets for identical assets or liabilities.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities</td></tr> </table> The carrying value of financial assets and liabilities recorded at fair value are measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels. Basic and diluted earnings per share Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted earnings (loss) per share are computed on the basis of the weighted average number of common shares (including common stock subject to redemption) plus dilutive potential common shares outstanding for the reporting period. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect. Stock Based Compensation In accordance with ASC No. 718, Compensation – Stock Compensation (“ASC 718”), we measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant. Non-Employee Stock-Based Compensation In accordance with ASC 505, Equity Based Payments to Non-Employees, issuances of the Company’s common stock or warrants for acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently large disincentive for nonperformance) or (ii) the date at which performance is complete. Although situations may arise in which counter performance may be required over a period of time, the equity award granted to the party performing the service is fully vested and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist as the instruments fully vested on the date of agreement, the Company determines such date to be the measurement date and will record the estimated fair market value of the instruments granted as a prepaid expense and amortize such amount to general and administrative expense in the accompanying statement of operations over the contract period. When it is appropriate for the Company to recognize the cost of a transaction during financial reporting periods prior to the measurement date, for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values at each of those interim financial reporting dates. Reclassifications Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the Unaudited Condensed Consolidated Statements of Operations for three months ended March 31, 2021, to reclass $<span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zCDZmNNLmme4" title="Research and development expense">93,266 of costs to research and development previously classified in general and administrative. In addition, an adjustment has been made to the Unaudited Condensed Consolidated Balance Sheets as of December 31, 2021, to reclass $1,072 of other current liabilities previously classified in accrued payroll and payroll taxes. Concentrations, Risks, and Uncertainties Business Risk Substantial business risks and uncertainties are inherent to an entity, including the potential risk of business failure. The Company is headquartered and operates in the United States. To date, the Company has generated no revenues from operations. There can be no assurance that the Company will be able to raise additional capital and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. Currently, these contingencies include general economic conditions, price of components, competition, and governmental and political conditions. Interest rate risk Financial assets and liabilities do not have material interest rate risk. Credit risk The Company is exposed to credit risk from its cash in banks. The credit risk on cash in banks is limited because the counterparties are recognized financial institutions. Seasonality The business is not subject to substantial seasonal fluctuations. Major Suppliers Sigyn Therapy is comprised of components that are supplied by various industry vendors. Additionally, the Company is reliant on third-party organizations to conduct clinical development studies that are necessary to advance Sigyn Therapy toward the marketplace. Should the relationship with an industry vendor or third-party clinical development organization be interrupted or discontinued, it is believed that alternate component suppliers and third-party clinical development organizations could be identified to support the continued advancement of Sigyn Therapy. Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes. This standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, Income Taxes, while also clarifying and amending existing guidance, including interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU No. 2019-12 in the first quarter of fiscal 2021, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In August 2020, the FASB issued ASU No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This ASU is effective for annual reporting periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted ASU No. 2020-06 in the first quarter of fiscal 2021, coinciding with the standard’s effective date, and had an immaterial impact from this standard s. Other recently issued accounting updates are not expected to have a material impact on the Company’s unaudited condensed consolidated financial statements.

Use of Estimates The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Actual results may differ from those estimates and such differences may be material to the financial statements. The more significant estimates and assumptions by management include among others: common stock valuation, and the recoverability of intangibles. The current economic environment has increased the degree of uncertainty inherent in these estimates and assumptions.

Cash The Company’s cash is held in bank accounts in the United States and is insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. The Company has not experienced any cash losses.

250000

Income Taxes Income taxes are accounted for under an asset and liability approach. This process involves calculating the temporary and permanent differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The temporary differences result in deferred tax assets and liabilities, which would be recorded on the Balance Sheets in accordance with ASC 740, which established financial accounting and reporting standards for the effect of income taxes. The likelihood that its deferred tax assets will be recovered from future taxable income must be assessed and, to the extent that recovery is not likely, a valuation allowance is established. Changes in the valuation allowance in a period are recorded through the income tax provision in the consolidated Statements of Operations. ASC 740-10-30 was adopted from the date of its inception. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in an entity’s consolidated financial statements and prescribes a recognition threshold and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on a tax return. Under ASC 740-10, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, ASC 740-10 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As a result of the implementation of ASC 740-10 and currently, the Company does not have a liability for unrecognized income tax benefits.

less than a 50% likelihood

Advertising and Marketing Costs Advertising expenses are recorded as general and administrative expenses when they are incurred. The Company had advertising expenses of $250 and $82,250 for the three months ended March 31, 2022 and 2021, respectively.

250

82250

Inventories In conjunction with the October 19, 2020 Share Exchange Agreement, the Company kept the gem inventory of Reign Resources Corporation. Inventories are stated at the lower of cost or market (net realizable value) on a lot basis each quarter. A lot is determined by the cut, clarity, size, and weight of the sapphires. Inventory consists of sapphire jewels that meet rigorous grading criteria and are of cuts and sizes most commonly used in the jewelry industry. As of March 31, 2022 and December 31, 2021, the Company carried primarily loose sapphire jewels, jewelry for sale on our website, and jewelry held as samples. Samples are used to show potential customers what the jewelry would look like. Promotional items given to customers that are not expected to be returned will be removed from inventory and expensed. There have been no promotional items given to customers as of March 31, 2022. The Company performs its own in-house assessment based on gem guide and the current market price for metals to value its inventory on an annual basis or if circumstances dictate sooner to determine if the estimated fair value is greater or less than cost. In addition, the inventory is reviewed each quarter by the Company against industry prices from gem-guide and if there is a potential impairment, the Company would appraise the inventory. The estimated fair value is subject to significant change due to changes in popularity of cut, perceived grade of the clarity of the sapphires, the number, type and size of inclusions, the availability of other similar quality and size sapphires, and other factors. As a result, the internal assessed value of the sapphires could be significantly lower from the current estimated fair value. Loose sapphire jewels do not degrade in quality over time. Based on the significant advancement of Sigyn Therapy, the Company decided in the 4th quarter of 2021 to assess the value of retail business operations that were a focus of the Company prior to the merger transaction consummated on October 19, 2020. Related to this assessment, management determined the wholesale liquidation value of its sapphire gem inventory to be 5-10% of the previously reported retail value, based on communications with certified gemologists, the variance between retail and wholesale valuations, and current market conditions. As a result, the Company has valued the inventory at $50,000 and recorded an impairment of assets of $536,047 in the year ended December 31, 2021.

50000

536047

Property and Equipment Property and equipment are carried at cost and are depreciated on a straight-line basis over the estimated useful lives of the assets, generally five years. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

P5Y

Intangible Assets Intangible assets consist primarily of website development costs. Our intangible assets are being amortized on a straight-line basis over a period of three years.

P3Y

Impairment of Long-lived Assets We periodically evaluate whether the carrying value of property, equipment and intangible assets has been impaired when circumstances indicate the carrying value of those assets may not be recoverable. The carrying amount is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying value is not recoverable, the impairment loss is measured as the excess of the asset’s carrying value over its fair value. Our impairment analyses require management to apply judgment in estimating future cash flows as well as asset fair values, including forecasting useful lives of the assets, assessing the probability of different outcomes, and selecting the discount rate that reflects the risk inherent in future cash flows. If the carrying value is not recoverable, we assess the fair value of long-lived assets using commonly accepted techniques, and may use more than one method, including, but not limited to, recent third-party comparable sales and discounted cash flow models. If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future. As of March 31, 2022 and December 31, 2021, the Company had not experienced impairment losses on its long-lived assets.

Fair Value of Financial Instruments The provisions of accounting guidance, FASB Topic ASC 825 requires all entities to disclose the fair value of financial instruments, both assets and liabilities recognized and not recognized on the balance sheet, for which it is practicable to estimate fair value, and defines fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. As of March 31, 2022 and December 31, 2021, the fair value of cash, accounts payable, accrued expenses, and notes payable approximated carrying value due to the short maturity of the instruments, quoted market prices or interest rates which fluctuate with market rates.

Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 1 – Quoted prices in active markets for identical assets or liabilities.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities</td></tr> </table> The carrying value of financial assets and liabilities recorded at fair value are measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels.

Basic and diluted earnings per share Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted earnings (loss) per share are computed on the basis of the weighted average number of common shares (including common stock subject to redemption) plus dilutive potential common shares outstanding for the reporting period. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect.

Stock Based Compensation In accordance with ASC No. 718, Compensation – Stock Compensation (“ASC 718”), we measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Non-Employee Stock-Based Compensation In accordance with ASC 505, Equity Based Payments to Non-Employees, issuances of the Company’s common stock or warrants for acquiring goods or services are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The measurement date for the fair value of the equity instruments issued to consultants or vendors is determined at the earlier of (i) the date at which a commitment for performance to earn the equity instruments is reached (a “performance commitment” which would include a penalty considered to be of a magnitude that is a sufficiently large disincentive for nonperformance) or (ii) the date at which performance is complete. Although situations may arise in which counter performance may be required over a period of time, the equity award granted to the party performing the service is fully vested and non-forfeitable on the date of the agreement. As a result, in this situation in which vesting periods do not exist as the instruments fully vested on the date of agreement, the Company determines such date to be the measurement date and will record the estimated fair market value of the instruments granted as a prepaid expense and amortize such amount to general and administrative expense in the accompanying statement of operations over the contract period. When it is appropriate for the Company to recognize the cost of a transaction during financial reporting periods prior to the measurement date, for purposes of recognition of costs during those periods, the equity instrument is measured at the then-current fair values at each of those interim financial reporting dates.

Reclassifications Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the Unaudited Condensed Consolidated Statements of Operations for three months ended March 31, 2021, to reclass $<span id="xdx_90C_eus-gaap--ResearchAndDevelopmentExpense_c20220101__20220331__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zCDZmNNLmme4" title="Research and development expense">93,266 of costs to research and development previously classified in general and administrative. In addition, an adjustment has been made to the Unaudited Condensed Consolidated Balance Sheets as of December 31, 2021, to reclass $1,072 of other current liabilities previously classified in accrued payroll and payroll taxes.

93266

1072

Concentrations, Risks, and Uncertainties Business Risk Substantial business risks and uncertainties are inherent to an entity, including the potential risk of business failure. The Company is headquartered and operates in the United States. To date, the Company has generated no revenues from operations. There can be no assurance that the Company will be able to raise additional capital and failure to do so would have a material adverse effect on the Company’s financial position, results of operations and cash flows. Also, the success of the Company’s operations is subject to numerous contingencies, some of which are beyond management’s control. Currently, these contingencies include general economic conditions, price of components, competition, and governmental and political conditions. Interest rate risk Financial assets and liabilities do not have material interest rate risk. Credit risk The Company is exposed to credit risk from its cash in banks. The credit risk on cash in banks is limited because the counterparties are recognized financial institutions. Seasonality The business is not subject to substantial seasonal fluctuations. Major Suppliers Sigyn Therapy is comprised of components that are supplied by various industry vendors. Additionally, the Company is reliant on third-party organizations to conduct clinical development studies that are necessary to advance Sigyn Therapy toward the marketplace. Should the relationship with an industry vendor or third-party clinical development organization be interrupted or discontinued, it is believed that alternate component suppliers and third-party clinical development organizations could be identified to support the continued advancement of Sigyn Therapy.

Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes. This standard simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, Income Taxes, while also clarifying and amending existing guidance, including interim-period accounting for enacted changes in tax law. This standard is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU No. 2019-12 in the first quarter of fiscal 2021, coinciding with the standard’s effective date, and had an immaterial impact from this standard. In August 2020, the FASB issued ASU No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. This ASU is effective for annual reporting periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. The Company adopted ASU No. 2020-06 in the first quarter of fiscal 2021, coinciding with the standard’s effective date, and had an immaterial impact from this standard s. Other recently issued accounting updates are not expected to have a material impact on the Company’s unaudited condensed consolidated financial statements.

NOTE 4 – PROPERTY AND EQUIPMENT Property and equipment consisted of the following as of: SCHEDULE OF PROPERTY AND EQUIPMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Estimated Life</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 47%; text-align: left">Office equipment</td><td style="width: 2%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zZGzBMQj0FQ2" title="Estimated useful life">5 years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zX7EU9uHfF9g" style="width: 14%; text-align: right" title="Equipment gross">28,181</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zxVwYrsFVvU8" style="width: 14%; text-align: right" title="Equipment gross">28,181</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Computer equipment</td><td> </td> <td style="text-align: center"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zi2mpjTEZpbk" title="Estimated useful life">3 years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zhuXQO61lbX5" style="text-align: right" title="Equipment gross">3,157</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z7F4V7AA5DM" style="text-align: right" title="Equipment gross">3,157</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220331_zo36mNsNDzyi" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(4,996</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z6gFBBjihY64" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(3,292</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20220331_zEDuu2Lgn8ed" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">26,342</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zAoLAEPqGfc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">28,046</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Depreciation expense was $1,704 and $344 for the three months ended March 31, 2022 and 2021, respectively, and is classified in general and administrative expenses in the unaudited condensed consolidated Statements of Operations.

Property and equipment consisted of the following as of: SCHEDULE OF PROPERTY AND EQUIPMENT <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: center">March 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Estimated Life</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 47%; text-align: left">Office equipment</td><td style="width: 2%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zZGzBMQj0FQ2" title="Estimated useful life">5 years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zX7EU9uHfF9g" style="width: 14%; text-align: right" title="Equipment gross">28,181</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zxVwYrsFVvU8" style="width: 14%; text-align: right" title="Equipment gross">28,181</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Computer equipment</td><td> </td> <td style="text-align: center"><span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zi2mpjTEZpbk" title="Estimated useful life">3 years</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20220331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zhuXQO61lbX5" style="text-align: right" title="Equipment gross">3,157</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_z7F4V7AA5DM" style="text-align: right" title="Equipment gross">3,157</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20220331_zo36mNsNDzyi" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(4,996</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z6gFBBjihY64" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(3,292</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20220331_zEDuu2Lgn8ed" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">26,342</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zAoLAEPqGfc4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">28,046</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

P5Y

28181

P3Y

3157

4996

3292

26342

28046

1704

344

NOTE 5 – INTANGIBLE ASSETS Intangible assets consisted of the following as of: SCHEDULE OF INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Estimated life</td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20220331_zCTTP6y22PY4" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2022</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20211231_zbTu8RgwGKr1" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="text-align: center; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maFLIANzMoV_z4FaC8EbyGR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 39%">Website</td><td style="width: 2%"> </td> <td style="width: 15%; text-align: center">3 years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">10,799</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">10,799</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msFLIANzMoV_zQMpjzJyVimg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,999</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,099</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzMoV_zeRePJ4DJ3Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,700</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of March 31, 2022, estimated future amortization expenses related to intangible assets were as follows: SCHEDULE OF ESTIMATED AMORTIZATION EXPENSES RELATED TO INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20220331_zRKhIJKLsqZ1" style="border-bottom: Black 1pt solid; text-align: center">Intangible Assets</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_z9g9sn8HqQI8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 79%">2022 (remaining 9 months)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">2,100</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zIV1tDVkzqxf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,100</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zBJ5I5yZYOAe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company had amortization expense of $900 and $10,354 for the three months ended March 31, 2022 and 2021, respectively. On January 8, 2020, James Joyce, the Company’s CEO and Craig Roberts, the Company’s CTO, assigned to the Company the rights to patent 62/881,740 pertaining to the devices, systems and methods for the broad-spectrum reduction of pro-inflammatory cytokines in blood.

Intangible assets consisted of the following as of: SCHEDULE OF INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Estimated life</td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20220331_zCTTP6y22PY4" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2022</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20211231_zbTu8RgwGKr1" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="text-align: center; padding-bottom: 1pt"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maFLIANzMoV_z4FaC8EbyGR5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 39%">Website</td><td style="width: 2%"> </td> <td style="width: 15%; text-align: center">3 years</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">10,799</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">10,799</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msFLIANzMoV_zQMpjzJyVimg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,999</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,099</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzMoV_zeRePJ4DJ3Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"> Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,700</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

P3Y

10799

5999

5099

4800

5700

As of March 31, 2022, estimated future amortization expenses related to intangible assets were as follows: SCHEDULE OF ESTIMATED AMORTIZATION EXPENSES RELATED TO INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20220331_zRKhIJKLsqZ1" style="border-bottom: Black 1pt solid; text-align: center">Intangible Assets</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_z9g9sn8HqQI8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 79%">2022 (remaining 9 months)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">2,100</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zIV1tDVkzqxf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,100</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zBJ5I5yZYOAe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Intangible assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,800</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2100

4800

900

10354

NOTE 6 – CONVERTIBLE PROMISSORY DEBENTURES Convertible notes payable consisted of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"/><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zVavTxztvQUg" style="width: 16%; text-align: right" title="Convertible notes payable">457,380</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_ziAdzbfVzcdc" style="width: 16%; text-align: right" title="Convertible notes payable">457,380</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">January 28, 2020 (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z6jTI6kBwis7" title="Convertible notes payable">$457,380) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zsIcJqU9msAh" title="Debt instrument interest rate">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zoyYdgjWfKVb" title="Debt instrument maturity date">October 20, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zJEzFUlmR6U8" style="text-align: right" title="Convertible notes payable">457,380</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zjBXTu2HvSEe" style="text-align: right" title="Convertible notes payable">457,380</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">June 23, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_z27iIMap52Q3" title="Convertible notes payable">60,500) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zbblSPCFLx61" title="Debt instrument interest rate">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20200620__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zdBwXPiGDly6" title="Debt instrument maturity date">October 20, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zHDQXFSpKzIb" style="text-align: right" title="Convertible notes payable">60,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zEYPtS1iBkb4" style="text-align: right" title="Convertible notes payable">60,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">September 17, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_z4l0V5jAQc3l" title="Convertible notes payable">199,650) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zEG8O35ziGX7" title="Debt instrument interest rate">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zm9py7DZLAt9" title="Debt instrument maturity date">October 20, 2022. On October 28, 2021, Osher elected to convert $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zMdCgSROTkO6" title="Aggregate principal amount of debt">16,714 of the aggregate principal amount of the Note of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtConversionOriginalDebtAmount1_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zP1iVyGVbe01" title="Debt conversion debt">199,650, into <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zjmHG2wWri4e" title="Debt conversion converted instrument shares">42,857 common shares.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zAxMkaG6vLqa" style="text-align: right" title="Convertible notes payable">182,936</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zJhZVFufl7a2" style="text-align: right" title="Convertible notes payable">182,936</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">March 23, 2022 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zJjLRLIXIVNl" title="Convertible notes payable">220,000) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zryUnyQlTN14">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20220322__20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zSBhdCVyOs5j" title="Debt instrument maturity date">October 23, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zSehGHAaJvb2" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible notes payable">220,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_z4UDbI7t0069" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible notes payable">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; font-style: italic; text-align: justify">Total convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_c20220331_zOUy4Ml8z8Hg" style="text-align: right" title="Convertible notes payable">920,816</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ConvertibleNotesPayable_iI_c20211231_z1FiOg7XvnHg" style="text-align: right" title="Convertible notes payable">700,816</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Original issue discount</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--DebtInstrumentOriginalDiscount_iI_c20220331_zGPpew3cP7fe" style="text-align: right" title="Original issue discount">(57,092</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--DebtInstrumentOriginalDiscount_iI_c20211231_z2rfaVaidS7g" style="text-align: right" title="Original issue discount">(53,614</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20220331_zCFiP2wVaaAc" style="border-bottom: Black 1pt solid; text-align: right" title="Debt discount">(158,804</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20211231_zGvhFpsTh152" style="border-bottom: Black 1pt solid; text-align: right" title="Debt discount">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20220331_z21xWBaFsSfj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total convertible notes payable">704,920</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20211231_zKO4w2kea128" style="border-bottom: Black 2.5pt double; text-align: right" title="Total convertible notes payable">647,202</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Principal payments on convertible promissory debentures are due as follows: SCHEDULE OF PRINCIPAL PAYMENTS DUE ON CONVERTIBLE PROMISSORY DEBENTURES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year ending December 31,</td><td> </td> <td colspan="2" id="xdx_493_20220331_zEBxoa1bGSB" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_maLTDzMXu_zWalHfj1Mm13" style="vertical-align: bottom; background-color: White"> <td style="width: 79%; text-align: left">2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">700,816</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maLTDzMXu_zsOgl61JxPL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">220,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iTI_mtLTDzMXu_zDHmQ0loyM0h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">920,816</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Current Noteholders Osher – $110,000 On March 23, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of <span id="xdx_902_eus-gaap--DebtConversionDescription_c20220321__20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zdANECAfKWgb" title="Debt conversion, description">(i) $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zjBRmdyBgr2f" title="Aggregate principal amount of debt">110,000 aggregate principal amount of Note due March 23, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zejNNVPQOyv3" title="Aggregate number of warrants to purchase shares">220,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zihbNQ2zyqN5" title="Exercise price of warrants per share">0.50 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20220321__20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z3n3Al0i7Vpf" title="Proceeds from issuance of convertible debt">100,000 which was issued at a $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zFd8tWWczCsj" title="Original issue discount amount">10,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zTSvRWPmni48" title="Debt instrument conversion price per share">0.50 per share, subject to adjustment as provided therein, such as stock splits and stock dividends. Brio – $110,000 On March 23, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “Note”) with respect to the sale and issuance to institutional investor Brio Capital Master Fund Ltd. (“Brio”) of <span id="xdx_909_eus-gaap--DebtConversionDescription_c20220321__20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--BrioCapitalMasterFundLtdMember_zwsQrsbe2moe" title="Debt conversion, description">(i) $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--BrioCapitalMasterFundLtdMember_zFbpOUl3v6O8" title="Aggregate principal amount of debt">110,000 aggregate principal amount of Note due March 23, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--BrioCapitalMasterFundLtdMember_zPMVR5b4ksE8" title="Aggregate number of warrants to purchase shares">220,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--BrioCapitalMasterFundLtdMember_zEI4CllA03i3" title="Exercise price of warrants per share">0.50 per share. The aggregate cash subscription amount received by the Company from the previous noteholder for the issuance of the Note and Warrants was $<span id="xdx_90A_eus-gaap--ProceedsFromConvertibleDebt_c20220321__20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--BrioCapitalMasterFundLtdMember_zKbnDz01U7kl" title="Proceeds from issuance of convertible debt">100,000 which was issued at a $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--BrioCapitalMasterFundLtdMember_zUM7lo9PYD2" title="Original issue discount amount">10,000 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--BrioCapitalMasterFundLtdMember_zRPATVuY5r41" title="Debt instrument conversion price per share">0.50 per share, subject to adjustment as provided therein, such as stock splits and stock dividends. Osher – $457,380 On January 28, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of <span id="xdx_90C_eus-gaap--DebtConversionDescription_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zB7wuHEe5Txl" title="Debt conversion, description">(i) $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z62sUvZQ8Hye" title="Aggregate principal amount of debt">385,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture due <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zmOcSDsKBG22" title="Debt instrument maturity date">January 26, 2021, based on $1.00 for each $0.90909 paid by Osher and (ii) <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zN0Jgohe3QPa" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants to purchase up to an aggregate of <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zIho4sgzjPk" title="Aggregate number of warrants to purchase shares">80,209 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zlb1ZC9oJbAd" title="Exercise price of warrants per share">7.00 per share. The aggregate cash subscription amount received by the Company from Osher for the issuance of the note and warrants was $<span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zw3hh8mu6429" title="Proceeds from issuance of convertible debt">350,005 which was issued at a $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zosVztumXjij" title="Original issue discount amount">34,995 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zTY1G9aGzk91" title="Debt instrument conversion price per share">0.094 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and Osher amended the convertible debt agreement as follows on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated January 28, 2020, for the number of warrant shares from <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z90o0485rpbi" title="Class of warrant or right, number of securities called by warrants or rights">80,209 warrant shares to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zdWF0Jy2lk87" title="Aggregate number of warrants to purchase shares">4,113,083 warrant shares at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_z4CYj8ZLqK43" title="Exercise price of warrants per share">0.14 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note to provide for interest at <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zelYoWoKGXD1" title="Debt instrument interest rate stated percentage">8% per annum.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zI7Fk3p6qDxj" title="Debt instrument, maturity date, description">maturity date from June 23, 2021 to October 20, 2021.</td></tr> </table> On October 22, 2021, the Company and Osher amended convertible debt agreements as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the <span id="xdx_90C_eus-gaap--DebtInstrumentMaturityDateDescription_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zjX846eLYj37" title="Debt instrument, maturity date, description">maturity date from October 20, 2021 to October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $<span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_pp0p0_c20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zNOmpgl7qw28" title="Principal amount">652,300 to $<span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z4kwzFD5FHD8" title="Principal amount">717,530 which is issued at a $<span id="xdx_908_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zYiiYvVD17pi" title="Accrued interest">65,230 original issue discount from the face value of the October 20, 2020 Notes now due October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In exchange for the extension of the Note, the Company issued Osher <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zEwzzqbo9Czj" title="Term of warrants::XDX::P5Y">five-year warrants to purchase an aggregate of <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zLVFhiRpIkHj" title="Aggregate number of warrants to purchase shares">450,000 shares of the Company’s common stock at an exercise price of $1.00 per share.</td></tr> </table> Osher – $60,500 (as amended on October 20, 2020 to $55,000) On June 23, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of <span id="xdx_904_eus-gaap--DebtConversionDescription_c20200622__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_ztW93qPZOOCf" title="Debt conversion, description">(i) $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zaDlkVgR0gKf" title="Debt instrument, face amount">50,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20200622__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zODCN3XBLiq3" title="Debt instrument, maturity date">June 23, 2021, based on $1.00 for each $0.90909 paid by Osher and (ii)<span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_ztkicIcEWo8j" title="Term of warrants::XDX::P5Y"> five-year Common Stock Purchase Warrants (“Warrants”) to purchase up to an aggregate of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zHs51sMImnnl" title="Aggregate number of warrants to purchase shares">10,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zae1Jf7QUPDa" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from Osher for the issuance of the Note and Warrants was $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20200622__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z4UNjzJ0qHJk" title="Proceeds from issuance of convertible debt">50,005 which was issued at a $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zC52H4ARDmwa" title="Original issue discount amount">0 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zJLkLINdPDZh" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and Osher amended the convertible debt agreement as follow on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the aggregate principal amount from $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zf5GB0x1oJp1" title="Aggregate principal amount of debt">50,000 to $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zgxGQFUXT2Vh" title="Aggregate principal amount of debt">55,000. The aggregate cash subscription amount received by the Company from Osher for the issuance of the Note and Warrants was $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zYOeSfYrNQmb" title="Proceeds from issuance of convertible debt">50,005 which was issued at an amended $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zEUvd1dlHzpk" title="Original issue discount amount">4,995 original issue discount from the face value of the Note.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated June 23, 2020, for the number of warrant shares from <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zjLXnYLRLnD9" title="Class of warrant or right, number of securities called by warrants or rights">10,000 warrant shares to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_zYUhiX60MAsa" title="Aggregate number of warrants to purchase shares">141,020 warrant shares at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember_z5yZFLNBgWFd" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDateDescription_c20201018__20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementTwoMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z0CZNwWXiS5k" title="Debt instrument, maturity date, description">maturity date from June 23, 2021 to October 20, 2021.</td></tr> </table> On October 22, 2021, the Company and Osher amended convertible debt agreements as follows (see Note 12): <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDateDescription_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zBf8SnHmAHU4" title="Debt instrument, maturity date, description">maturity date from October 20, 2021 to October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $<span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zE3bBaHc8aUh" title="Principal amount">652,300 to $<span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zItGmqvaVzGj" title="Principal amount">717,530 which is issued at a $<span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z4BMVp4MJask" title="Accrued interest">65,230 original issue discount from the face value of the October 20, 2020 Notes now due October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In exchange for the extension of the Note, the Company issued Osher <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zfEONdCBZB7f" title="Warrant term::XDX::P5Y">five-year warrants to purchase an aggregate of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zyyCFXllhbWh" title="Number of securities called by warrants">450,000 shares of the Company’s common stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zOyBzJZQJ4T3" title="Exercise price">1.00 per share.</td></tr> </table> Osher – $199,650 On September 17, 2020 (the “Original Issue Date”), the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with respect to the sale and issuance to institutional investor Osher Capital Partners LLC (“Osher”) of <span id="xdx_906_eus-gaap--DebtConversionDescription_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zWPbxde6sLm5" title="Debt conversion, description">(i) $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zijt0psytnqh" title="Debt instrument, face amount">181,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zNTL7U68gcM5" title="Debt instrument maturity date">September 30, 2021, based on $1.00 for each $0.90909 paid by Osher and (ii) <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zD8QFN6ZiYId" title="Term of warrants::XDX::P5Y">five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zr5DoLOlypWl" title="Aggregate number of warrants to purchase shares">8,250 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zOvbvjvHanw6" title="Exercise price of warrants per share">30.00 per share. The aggregate cash subscription amount received by the Company from Osher for the issuance of the Note and Warrants was $<span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zw3IpDXDwCm5" title="Proceeds from issuance of convertible debt">165,000 which was issued at a $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zDNRdNQ4DvTc" title="Original issue discount amount">16,500 original issue discount from the face value of the Note. The conversion price for the principal in connection with voluntary conversions by a holder of the convertible notes is $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_z3TlD8fjKN35" title="Debt instrument conversion price per share">0.39 per share, as amended on October 20, 2020, subject to adjustment as provided therein, such as stock splits and stock dividends. The Company and Osher amended the convertible debt agreement as follow on October 20, 2020: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Warrants dated September 17, 2020, for the number of warrant shares from <span id="xdx_901_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zUFOlMTPo8Ai" title="Class of warrant or right, number of securities called by warrants or rights">8,250 warrant shares to <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_zv5ZjXPsXLOe" title="Aggregate number of warrants to purchase shares">465,366 warrant shares at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_ze7VxUazyuJ8" title="Exercise price of warrants per share">0.59 per share.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the Note for the <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--AmendedConvertibleDebtAgreementMember_z5G3zZHJAcKf" title="Debt instrument, maturity date, description">maturity date from September 30, 2021 to October 20, 2021.</td></tr> </table> On October 22, 2021, the Company and Osher amended convertible debt agreements as follows (see Note 12): <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the <span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDateDescription_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_za3xcvDWRvh3" title="Debt instrument, maturity date, description">maturity date from October 20, 2021 to October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The parties amended the October 20, 2020 Notes for the aggregate principal amount and accrued interest from $<span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20201020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zvryVtQMm24g" title="Principal amount">652,300 to $<span id="xdx_90B_eus-gaap--DebtInstrumentCarryingAmount_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zHf9RFB2CEC2" title="Principal amount">717,530 which is issued at a $<span id="xdx_906_eus-gaap--DebtInstrumentIncreaseAccruedInterest_pp0p0_c20211019__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zXGrFYPPTXq7" title="Accrued interest">65,230 original issue discount from the face value of the October 20, 2020 Notes now due October 20, 2022.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">In exchange for the extension of the Note, the Company issued Osher<span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zEYVoI61vWhl" title="Term of warrants::XDX::P5Y"> five-year warrants to purchase an aggregate of <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zkd9uolcEzXa" title="Aggregate number of warrants to purchase shares">450,000 shares of the Company’s common stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zGBwVyOUMPSh" title="Exercise price of warrants per share">1.00 per share.</td></tr> </table> On October 28, 2021, Osher elected to convert $<span id="xdx_90D_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zVs7zEodgVc8" title="Debt principal amount converted">16,714 of the aggregate principal amount of the Note of $<span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_dd_c20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zqV0U4jbEaKc" title="Debt instrument carrying amount">199,650, into<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zY1rFA15tJth" title="Shares issued upon conversion of debt"> 42,857 common shares. Previous Noteholders Previous notes were detailed in our Form 10-K filed on March 31, 2022. No changes occurred related to these notes during the period covered by this Form 10-Q.

Convertible notes payable consisted of the following: SCHEDULE OF CONVERTIBLE NOTES PAYABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"/><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zVavTxztvQUg" style="width: 16%; text-align: right" title="Convertible notes payable">457,380</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_ziAdzbfVzcdc" style="width: 16%; text-align: right" title="Convertible notes payable">457,380</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">January 28, 2020 (<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_z6jTI6kBwis7" title="Convertible notes payable">$457,380) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zsIcJqU9msAh" title="Debt instrument interest rate">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20200126__20200128__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zoyYdgjWfKVb" title="Debt instrument maturity date">October 20, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zJEzFUlmR6U8" style="text-align: right" title="Convertible notes payable">457,380</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zjBXTu2HvSEe" style="text-align: right" title="Convertible notes payable">457,380</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">June 23, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_z27iIMap52Q3" title="Convertible notes payable">60,500) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zbblSPCFLx61" title="Debt instrument interest rate">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20200620__20200623__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zdBwXPiGDly6" title="Debt instrument maturity date">October 20, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zHDQXFSpKzIb" style="text-align: right" title="Convertible notes payable">60,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteTwoMember_zEYPtS1iBkb4" style="text-align: right" title="Convertible notes payable">60,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">September 17, 2020 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_z4l0V5jAQc3l" title="Convertible notes payable">199,650) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zEG8O35ziGX7" title="Debt instrument interest rate">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20200915__20200917__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zm9py7DZLAt9" title="Debt instrument maturity date">October 20, 2022. On October 28, 2021, Osher elected to convert $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zMdCgSROTkO6" title="Aggregate principal amount of debt">16,714 of the aggregate principal amount of the Note of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--DebtConversionOriginalDebtAmount1_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zP1iVyGVbe01" title="Debt conversion debt">199,650, into <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211027__20211028__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zjmHG2wWri4e" title="Debt conversion converted instrument shares">42,857 common shares.</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zAxMkaG6vLqa" style="text-align: right" title="Convertible notes payable">182,936</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteThreeMember_zJhZVFufl7a2" style="text-align: right" title="Convertible notes payable">182,936</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">March 23, 2022 ($<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zJjLRLIXIVNl" title="Convertible notes payable">220,000) – <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zryUnyQlTN14">0% interest per annum outstanding principal and interest due <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTlZFUlRJQkxFIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_dd_c20220322__20220323__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zSBhdCVyOs5j" title="Debt instrument maturity date">October 23, 2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ConvertibleNotesPayable_iI_c20220331__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_zSehGHAaJvb2" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible notes payable">220,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConvertibleNotesPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteFourMember_z4UDbI7t0069" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible notes payable">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; font-style: italic; text-align: justify">Total convertible notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ConvertibleNotesPayable_iI_c20220331_zOUy4Ml8z8Hg" style="text-align: right" title="Convertible notes payable">920,816</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ConvertibleNotesPayable_iI_c20211231_z1FiOg7XvnHg" style="text-align: right" title="Convertible notes payable">700,816</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify">Original issue discount</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--DebtInstrumentOriginalDiscount_iI_c20220331_zGPpew3cP7fe" style="text-align: right" title="Original issue discount">(57,092</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--DebtInstrumentOriginalDiscount_iI_c20211231_z2rfaVaidS7g" style="text-align: right" title="Original issue discount">(53,614</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1pt">Debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20220331_zCFiP2wVaaAc" style="border-bottom: Black 1pt solid; text-align: right" title="Debt discount">(158,804</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--DebtInstrumentUnamortizedDiscount_iNI_di_c20211231_zGvhFpsTh152" style="border-bottom: Black 1pt solid; text-align: right" title="Debt discount">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total convertible notes payable</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_983_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20220331_z21xWBaFsSfj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total convertible notes payable">704,920</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--ConvertibleNotesPayableCurrent_iI_c20211231_zKO4w2kea128" style="border-bottom: Black 2.5pt double; text-align: right" title="Total convertible notes payable">647,202</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

457380

2022-10-20

457380

60500

2022-10-20

60500

199650

2022-10-20

16714

199650

42857

182936

220000

2023-10-23

220000

920816

700816

-57092 -53614

158804

704920

647202

Principal payments on convertible promissory debentures are due as follows: SCHEDULE OF PRINCIPAL PAYMENTS DUE ON CONVERTIBLE PROMISSORY DEBENTURES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Year ending December 31,</td><td> </td> <td colspan="2" id="xdx_493_20220331_zEBxoa1bGSB" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_maLTDzMXu_zWalHfj1Mm13" style="vertical-align: bottom; background-color: White"> <td style="width: 79%; text-align: left">2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 17%; text-align: right">700,816</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_maLTDzMXu_zsOgl61JxPL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">2023</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">220,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LongTermDebt_iTI_mtLTDzMXu_zDHmQ0loyM0h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">920,816</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

700816

220000

920816

(i) $110,000 aggregate principal amount of Note due March 23, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder

110000

220000

0.50

100000

10000

0.50

(i) $110,000 aggregate principal amount of Note due March 23, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder

110000

220000

0.50

100000

10000

0.50

(i) $385,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture due January 26, 2021, based on $1.00 for each $0.90909 paid by Osher

385000

2021-01-26

80209

7.00

350005

34995

0.094

80209

4113083

0.14

0.08

maturity date from June 23, 2021 to October 20, 2021

maturity date from October 20, 2021 to October 20, 2022

652300

717530

65230

450000

(i) $50,000 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due June 23, 2021, based on $1.00 for each $0.90909 paid by Osher

50000

2021-06-23

10000

30.00

50005

0.39

50000

55000

50005

4995

10000

141020

0.59

maturity date from June 23, 2021 to October 20, 2021

maturity date from October 20, 2021 to October 20, 2022

652300

717530

65230

450000

1.00

(i) $181,500 aggregate principal amount of Original Issue Discount Senior Convertible Debenture (the “Note”) due September 30, 2021, based on $1.00 for each $0.90909 paid by Osher

181500

2021-09-30

8250

30.00

165000

16500

0.39

8250

465366

0.59

maturity date from September 30, 2021 to October 20, 2021

maturity date from October 20, 2021 to October 20, 2022

652300

717530

65230

450000

1.00

16714

199650

42857

NOTE 7 – STOCKHOLDERS’ DEFICIT Preferred Stock The Company authorized 10,000,000 shares of par value $0.0001 preferred stock, of which none are issued and outstanding at March 31, 2022, and December 31, 2021, respectively. Common Stock The Company has authorized 1,000,000,000 shares of par value $0.0001 common stock, of which 37,295,803 shares are outstanding at March 31, 2022, and December 31, 2021, respectively. On October 28, 2021, Osher elected to convert $16,714 of the aggregate principal amount of the Note of $199,650, into <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211027__20211028__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zfycS4ywmSAl" title="Shares issued upon conversion of debt">42,857 common shares. On October 25, 2021, Osher elected to convert the aggregate principal amount of the Note, $<span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_dd_c20211025__us-gaap--TypeOfArrangementAxis__custom--MarketingConsultingAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zmGJUCFk43P4" title="Debt instrument carrying amount">110,000, into <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_dd_c20211024__20211025__us-gaap--TypeOfArrangementAxis__custom--MarketingConsultingAgreementMember__dei--LegalEntityAxis__custom--OsherCapitalPartnersLLCMember_zqiIkBLpEQC9" title="Shares issued upon conversion of debt">157,143 common shares. On October 20, 2021, the entered into a securities purchase agreement with an accredited investor that resulted in the issuance of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211018__20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zT7PahnYT3c8" title="Stock issued during period value shares issues">320,000 shares of common stock and warrants to purchase an aggregate of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zZMy3ETJQ6X3" title="Aggregate number of warrants to purchase shares">320,000 shares of the Company’s common stock for total proceeds totaling $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211018__20211020__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zs02YAeDhPti" title="Proceeds from issuance of common stock">400,000. The offering allowed for qualified investors to purchase one share of the Company’s common stock at $1.25. For each share purchased, the investor received a five-year warrant to purchase one share of common stock at $1.25 per share. No commissions were paid in the offering. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. On October 14, 2021, the Company issued a total of 47,000 shares of its common stock valued at $37,600 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for hosting webinar presentations with the financial community. On July 14, 2021, the Company issued a total of 47,000 shares of its common stock valued at $47,000 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for hosting webinar presentations with the financial community. On May 10, 2021, Brio Capital elected to convert the aggregate principal amount of a $110,000 convertible note issued on February 10, 2021 into 157,143 shares of the Company’s common stock. In April 2021, the Company initiated an offering of up to $1.5 million of the Company’s restricted common shares. The offering allowed for qualified investors to purchase one share of the Company’s common stock $1.25. For each share purchased, the investor received a five-year warrant to purchase one share of common stock at $1.75 per share. On May 10, 2021, the Company closed the offering to investors and subsequently disclosed that it had entered into securities purchase agreements with accredited investors that resulted in the issuance of 1,172,000 shares of common stock and warrants to purchase an aggregate of 1,172,000 shares of the Company’s common stock for total proceeds totaling $1,465,000. No commissions were paid in the offering. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. On April 14, 2021, the Company issued a total of 47,000 shares of its restricted common stock valued at $82,250 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for communications to the financial industry. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. On February 19, 2021, a previous noteholder exercised the warrants pursuant to the cashless exercise provision of the warrant agreement into <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210219__srt--TitleOfIndividualAxis__custom--PreviousNoteholderMember_zvCnM8fVlYf2" title="Aggregate numbers of warrants to purchase shares">57,147 common shares. The common shares have not been issued as of May 13, 2022. On January 14, 2021, the Company issued a total of 47,000 shares of its restricted common stock valued at $82,250 (based on the stock price of the Company’s common stock on the date of issuance) to a third party, for communications to the financial industry. This issuance was pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, in a transaction exempt from registration. Warrants On October 22, 2021, the Company and Osher amended convertible debt agreements for the maturity date from <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDateDescription_dd_c20211018__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zyUt6JXBX0K9" title="Debt maturity date, description">October 20, 2021 to October 20, 2022. In exchange for the extension of the Note, the Company issued Osher <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211018__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zFBShnzblkxa" title="Stock issued during period shares">450,000 warrants to purchase an aggregate of <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zcyP48WFxS93" title="Number of securities called by warrants">450,000 shares of the Company’s common stock, valued at $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20211018__20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zGXVnJaRIsZ1" title="Proceeds from issuance of common stock">197,501 (based on the Black Scholes valuation model on the date of grant) (see Note 6). The warrants are exercisable for a period of five years at $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211022__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zXtHqtdR4IV5" title="Exercise price of warrants per share">1.00 per share in whole or in part, as either a cash exercise or as a cashless exercise, and fully vest at grant date. The Company is accreting the value of the warrants ratably through October 20, 2022. The Company recorded $48,699 and $0 for the three months ended March 31, 2022 and 2021, respectively, and is classified in other expenses in the consolidated Statements of Operations.

10000000

0.0001

1000000000

0.0001

37295803 37295803

16714

199650

42857

110000

157143

320000

400000

47000

37600

47000

110000

157143

1500000

1.25

1172000

1465000

47000

82250

57147

47000

82250

October 20, 2021 to October 20, 2022.

450000

197501

1.00

48699

NOTE 8 – OPERATING LEASES On May 27, 2021, the Company entered into a sixty-three month lease for its corporate office at $5,955 per month commencing June 15, 2021 maturing September 30, 2026. The Company accounts for this lease in accordance with ASC 842. Adoption of the standard resulted in the initial recognition of operating lease ROU asset of $290,827 and operating lease liability of $290,827 as of June 15, 2021. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives. Our variable lease payments primarily consist of maintenance and other operating expenses from our real estate leases. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. We have lease agreements with lease and non-lease components. We have elected to account for these lease and non-lease components as a single lease component. We are also electing not to apply the recognition requirements to short-term leases of twelve months or less and instead will recognize lease payments as expense on a straight-line basis over the lease term. The components of lease expense and supplemental cash flow information related to leases for the period are as follows: In accordance with ASC 842, the components of lease expense were as follows: SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20220101__20220331_z2EzhcYHJRV9" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20210101__20210331_zQ8rVNpEzoNe" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseExpense_z5Jhzshq1E33" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Operating lease expense</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">17,919</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_zOAWPj3ZGcdh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Short term lease cost</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_z9sZ80yxeE9c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total lease expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">17,919</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> In accordance with ASC 842, other information related to leases was as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; font-style: italic">Three Months ended March 31,</td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Operating cash flows from operating leases</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeasePayments_pp0p0_c20220101__20220331_zGkhrYcrKG9i" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Operating cash flows from operating leases">17,866</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeasePayments_pp0p0_c20210101__20210331_zGqmr7zQpf2i" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Operating cash flows from operating leases">-</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Cash paid for amounts included in the measurement of lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_pp0p0_c20220101__20220331_z0g8TxRcpLV2" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">17,866</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_pp0p0_c20210101__20210331_zNKimvDB61S6" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average remaining lease term—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> 4.67 years </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average discount rate—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table> In accordance with ASC 842, maturities of operating lease liabilities as of March 31, 2022 were as follows: SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20220331_zlVsIdBLvki" style="font-weight: bold; text-align: center">Operating</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: left">Year ending:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lease</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzkR8_zSzsyyk9LfBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left; padding-left: 10pt">2022 (remaining 9 months)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">54,848</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzkR8_z2bIw9ZdzVqf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,895</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzkR8_zRbqKujK2ao6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,142</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzkR8_zCVNRAwXd48b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,456</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzkR8_zjTUDqrQMjV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">54,225</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzkR8_z6NYPsSqyiN7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total undiscounted cash flows</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">340,566</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reconciliation of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Weighted-average remaining lease terms</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> 4.67 years </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_zZ9nbpqcxyNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Weighted-average discount rate</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Present values</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">275,928</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iI_z6dmz2ACf8R6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Lease liabilities—current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">47,794</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zY7znbgAU7g6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Lease liabilities—long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">228,135</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiability_iI_zyoXSKynuAX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Lease liabilities—total</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">275,928</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zVf3JBRSsFCf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Difference between undiscounted and discounted cash flows</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">64,638</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> Operating lease cost was $17,919 and $0 for the three months ended March 31, 2022 and 2021, respectively.

5955

2026-09-30

290827

The components of lease expense and supplemental cash flow information related to leases for the period are as follows: In accordance with ASC 842, the components of lease expense were as follows: SCHEDULE OF OPERATING LEASE COST AND SUPPLEMENTAL CASH FLOW INFORMATION <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20220101__20220331_z2EzhcYHJRV9" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20210101__20210331_zQ8rVNpEzoNe" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months ended March 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseExpense_z5Jhzshq1E33" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Operating lease expense</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">17,919</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_zOAWPj3ZGcdh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Short term lease cost</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseCost_z9sZ80yxeE9c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Total lease expense</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">17,919</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> In accordance with ASC 842, other information related to leases was as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: left; font-weight: bold; font-style: italic">Three Months ended March 31,</td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">Operating cash flows from operating leases</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingLeasePayments_pp0p0_c20220101__20220331_zGkhrYcrKG9i" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Operating cash flows from operating leases">17,866</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingLeasePayments_pp0p0_c20210101__20210331_zGqmr7zQpf2i" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Operating cash flows from operating leases">-</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Cash paid for amounts included in the measurement of lease liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_pp0p0_c20220101__20220331_z0g8TxRcpLV2" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">17,866</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_984_ecustom--CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities_pp0p0_c20210101__20210331_zNKimvDB61S6" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid for amounts included in the measurement of lease liabilities">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted-average remaining lease term—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> 4.67 years </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average discount rate—operating leases</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table>

17919

17866

P4Y8M1D

0.10

In accordance with ASC 842, maturities of operating lease liabilities as of March 31, 2022 were as follows: SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20220331_zlVsIdBLvki" style="font-weight: bold; text-align: center">Operating</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: left">Year ending:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lease</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_iI_maLOLLPzkR8_zSzsyyk9LfBa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left; padding-left: 10pt">2022 (remaining 9 months)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">54,848</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzkR8_z2bIw9ZdzVqf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">74,895</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_maLOLLPzkR8_zRbqKujK2ao6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">77,142</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_maLOLLPzkR8_zCVNRAwXd48b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,456</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_maLOLLPzkR8_zjTUDqrQMjV1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">54,225</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzkR8_z6NYPsSqyiN7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total undiscounted cash flows</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">340,566</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reconciliation of lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Weighted-average remaining lease terms</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> 4.67 years </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_zZ9nbpqcxyNh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Weighted-average discount rate</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">10</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Present values</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">275,928</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iI_z6dmz2ACf8R6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Lease liabilities—current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">47,794</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_zY7znbgAU7g6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Lease liabilities—long-term</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">228,135</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OperatingLeaseLiability_iI_zyoXSKynuAX4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Lease liabilities—total</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">275,928</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zVf3JBRSsFCf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Difference between undiscounted and discounted cash flows</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">64,638</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

54848

74895

77142

79456

54225

340566

P4Y8M1D

0.10

47794

228135

275928

64638

17919

NOTE 9 – RELATED PARTY TRANSACTIONS Other than as set forth below, and as disclosed in Notes 5 and 7, there have not been any transaction entered into or been a participant in which a related person had or will have a direct or indirect material interest. Employment Agreements Mr. Ferrell was hired March 9, 2022 as the Company’s Chief Financial Officer. Mr. Ferrell receives an annual base salary of $<span id="xdx_908_eus-gaap--OfficersCompensation_pp0p0_c20220308__20220309__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_zpK0eBWO1TPa" title="Annual base salary">250,000, plus discretionary bonus compensation not to exceed <span id="xdx_908_ecustom--MaximumBonusCompensationPercentage_dp_uPure_c20220308__20220309__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_zMnlwb67rnU4" title="Maximum bonus compensation percentage">40% of salary. Mr. Ferrell’s employment also provides for medical insurance, disability benefits and three months of severance pay if his employment is terminated without cause or due to a change in control. Additionally, Mr. Ferrell will be granted up to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220308__20220309__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_zBi1lRUGltA7" title="Options granted">600,000 options to purchase <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220308__20220309__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_zlsPGDGcd228" title="Number of shares of common stock">600,000 of the Company’s common shares upon the implementation of a Company employee option plan. The Company incurred compensation expense of $<span id="xdx_900_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20220101__20220331__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_zqEW3UA39IXd" title="Compensation expense">10,417 and $<span id="xdx_90B_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20210101__20210331__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_z627M9Z2mkAh" title="Compensation expense">0 and employee benefits of $<span id="xdx_906_eus-gaap--PensionAndOtherPostretirementBenefitExpense_c20220101__20220331__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_zVRf4UUl5iFk" title="Employee benefits">1,140 and $<span id="xdx_90C_eus-gaap--PensionAndOtherPostretirementBenefitExpense_c20210101__20210331__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrFerrellMember_zwMbGyArg7S6" title="Employee benefits">0 for the three months ended March 31, 2022 and 2021, respectively.

250000

0.40

600000

10417

1140

NOTE 10 – EARNINGS PER SHARE FASB ASC Topic 260, Earnings Per Share, requires a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share (EPS) computations. Basic earnings (loss) per share are computed by dividing net earnings available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. In periods where losses are reported, the weighted-average number of common stock outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. Basic and diluted earnings (loss) per share are the same since net losses for all periods presented and including the additional potential common shares would have an anti-dilutive effect. The following table sets forth the computation of basic and diluted net income per share: SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20220101__20220331_zVlrRNUXbVQ5" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20210101__20210331_zVB9ywB2efX4" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_z5ut46GP2jQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net loss attributable to the common stockholders</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(678,046</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(461,682</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_ztk7whvZdrke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Basic weighted average outstanding shares of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37,295,803</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,266,601</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_z5nMlad66YT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Dilutive effect of options and warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_z8OGDqE6qIqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Diluted weighted average common stock and common stock equivalents</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">37,295,803</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">35,266,601</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_zHcdBDGT6ho" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.02</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

The following table sets forth the computation of basic and diluted net income per share: SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20220101__20220331_zVlrRNUXbVQ5" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20210101__20210331_zVB9ywB2efX4" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended March 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_405_eus-gaap--NetIncomeLoss_z5ut46GP2jQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Net loss attributable to the common stockholders</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(678,046</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">(461,682</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_ztk7whvZdrke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Basic weighted average outstanding shares of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">37,295,803</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,266,601</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_z5nMlad66YT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Dilutive effect of options and warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_z8OGDqE6qIqd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Diluted weighted average common stock and common stock equivalents</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">37,295,803</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">35,266,601</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--EarningsPerShareBasic_zHcdBDGT6ho" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.02</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.01</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table>

-678046

-461682

37295803

35266601

37295803

35266601

-0.02

-0.01

NOTE 11 – COMMITMENTS AND CONTINGENCIES Legal From time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any legal proceedings or claims that it believes will have a material adverse effect on its business, financial condition or operating results.

NOTE 12 – SUBSEQUENT EVENTS The Company evaluated all events or transactions that occurred after March 31, 2022 up through the date the financial statements were available to be issued. During this period, the Company did not have any material recognizable subsequent events required to be disclosed as of and for the period ended March 31, 2022 except for the following: On April 28, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “April 2022 Note”) totaling<span id="xdx_90C_eus-gaap--DebtConversionDescription_c20220426__20220428__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zKBJAVjW6d31" title="Debt conversion, description"> (i) $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20220428__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zq41aka8QLUf" title="Aggregate principal amount of debt">110,000 aggregate principal amount of April 2022 Note due April 28, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220428__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z9B3V9HCDT1i" title="Aggregate number of warrants to purchase shares">220,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220428__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwCeSArJHnTc" title="Exercise price of warrants per share">0.50 per share. The conversion price for the principal in connection with voluntary conversions by the holders of the convertible notes is $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220428__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdXvcjynFJ4f" title="Debt instrument conversion price per share">0.50 per share. On May 10, 2022, the Company entered into an Original Issue Discount Senior Convertible Debenture (the “May 2022 Note”) totaling <span id="xdx_901_eus-gaap--DebtConversionDescription_c20220508__20220510__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember_zwwpwivesDWi" title="Debt conversion, description">(i) $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20220510__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3DxH72XtI9c" title="Aggregate principal amount of debt">110,000 aggregate principal amount of Note due May 10, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants (“Warrants’) to purchase up to an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220510__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zLLiBnul157c" title="Aggregate number of warrants to purchase shares">220,000 shares of the Company’s Common Stock at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220510__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqb7JADevH76" title="Exercise price of warrants per share">0.50 per share. The conversion price for the principal in connection with voluntary conversions by the holders of the convertible notes is $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220510__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteOneMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zURwken11Fv" title="Debt instrument conversion price per share">0.50 per share.

(i) $110,000 aggregate principal amount of April 2022 Note due April 28, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder and (ii) five-year Common Stock Purchase Warrants

110000

220000

0.50

(i) $110,000 aggregate principal amount of Note due May 10, 2023 based on $1.00 for each $0.90909 paid by the previous noteholder

110000

220000

0.50